1. Cell Cycle/DNA Damage
    Cytoskeleton
  2. Microtubule/Tubulin

Docetaxel 

Cat. No.: HY-B0011 Purity: 99.80%
Data Sheet SDS Handling Instructions

Docetaxel is a semi-synthetic taxane analogue, acts as a microtubule stabilizer.

For research use only. We do not sell to patients.
Docetaxel Chemical Structure

Docetaxel Chemical Structure

CAS No. : 114977-28-5

Size Price Stock Quantity
Free sample   Apply now  
10 mM * 1 mL in DMSO $66 In-stock
100 mg $60 In-stock
200 mg $85 In-stock
500 mg   Get quote  
1 g   Get quote  

* Please select Quantity before adding items.

Other Forms of Docetaxel:

Top Publications Citing Use of Products
  • Biological Activity

  • Protocol

  • Technical Information

  • Purity & Documentation

  • References

Description

Docetaxel is a semi-synthetic taxane analogue, acts as a microtubule stabilizer.

IC50 & Target

Microtubule[1]

In Vitro

Docetaxel (DOC) and Glufosfamide (GLU) single and combined treatments affect the cells viability in a dose-dependent manner. The IC50 of GLU are 70±4 µM and 86.8±8 µM in PC-3 and LNCaP cells; respectively. While, the IC50 of Docetaxel alone is found to be 3.08±0.4 nM and 1.46±0.2 nM in PC-3 and LNCaP cells; respectively. The co-treatment of GLU with Docetaxel is found to synergize the cytotoxicity and the IC50 values are decreased to be 2.7±0.1 nM and 0.75±0.3 nM in PC-3 and LNCaP cells; respectively[1]. IC50 of NCI-H460 to Docetaxel at 24 h is 116 nM and at 72 h is 30 nM. According to data reported in DTP Data Search, the mean IC50 of NCI-60 cell panel to Docetaxel is 14-34 nM[2].

In Vivo

In female mice, the Docetaxel-induced intestinal apoptosis in the 14-hours after light on (HALO) group is significantly greater than that in the 2-HALO group. Bax expression is significantly elevated by Docetaxel in the 2-HALO group, but not in the 14-HALO group. On the other hand, cleaved Caspase-3 expression is significantly elevated by Docetaxel in the 14-HALO group, but not in the 2-HALO group. The expressions of Wee1 and phosphorylated CKD1 are significantly elevated after dosing of Docetaxel at 14 HALO, but not at 2 HALO. In addition, Docetaxel significantly reduces survivin expression in the 14-HALO group but not in the 2-HALO group. The survivin expression level in the Docetaxel-treated 14-HALO group is significantly smaller than that in the drug-treated 2-HALO group[3]. Piperine (PIP) is administrated via intravenous bolus at 3.5 mg/kg and via oral administration at 35 mg/kg and 3.5 mg/kg, while Docetaxel (DOX) is intravenously administrated at 7 mg/kg to Sprague-Daley rats. The co-administrations of PIP at 35 mg/kg via oral administration and Docetaxel at 7 mg/kg via intravenous bolus administration in Sprague-Dawley rats. The combination use of PIP and Docetaxel results in a synergic increase of both their in vivo exposure[4].

Clinical Trial
NCT Number Sponsor Condition Start Date Phase
NCT01110291 University of Turku|Sanofi|Turku University Hospital|Vaasa Central Hospital, Vaasa, Finland|medbase Oy Ltd CYP3A Phenotyping|CYP3A5 and MDR1 Genotyping|Docetaxel Toxicity|Associations Between Genetic Data and Docetaxel Toxicity April 2003
NCT00675545 National University Hospital, Singapore Hormone-Refractory Prostate Cancer May 2007 Phase 2
NCT00630110 Nereus Pharmaceuticals, Inc. Cancer February 2008 Phase 1|Phase 2
NCT00795171 Medical University of Vienna Hormone Refractory Prostate Cancer November 2008 Phase 2
NCT00606814 Infinity Pharmaceuticals, Inc. Solid Tumors December 2007 Phase 1
NCT01949519 Medical University of South Carolina|National Cancer Institute (NCI) Adenocarcinoma of the Prostate November 2013 Phase 1
NCT00714376 CHU de Quebec-Universite Laval Prostate Cancer May 2008 Phase 2
NCT00703378 National University Hospital, Singapore Solid Tumors May 2006 Phase 1|Phase 2
NCT01837667 Lixte Biotechnology Holdings, Inc. Tumors|Neoplasms|Cancer February 2013 Phase 1
NCT01254513 UNICANCER Prostate Cancer November 2010 Phase 2
NCT00248703 Oslo University Hospital|University of Tromso|Helse Stavanger HF|Sorlandet Hospital HF|Sykehuset Innlandet HF|Ullevaal University Hospital|Sykehuset i Vestfold HF|Sykehuset Ostfold|Alesund Hospital Breast Cancer October 2003 Phase 2
NCT00440128 GlaxoSmithKline Nausea and Vomiting, Chemotherapy-Induced May 2007 Phase 1
NCT00030407 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Lung Cancer October 2001 Phase 2
NCT00169000 Dartmouth-Hitchcock Medical Center|Hoffmann-La Roche Metastatic Breast Cancer January 2003 Phase 1
NCT00935961 Memorial Sloan Kettering Cancer Center|Novartis Pharmaceuticals HEAD & NECK Cancer July 2009 Phase 1
NCT00995761 Gyeongsang National University Hospital Non-small Cell Lung Cancer October 2009 Phase 2
NCT00294385 Central European Cooperative Oncology Group Breast Cancer June 2002 Phase 3
NCT00832338 Emory University|Sanofi Breast Neoplasms|Breast Cancer|Cancer of the Breast April 2009 Phase 2
NCT01693432 Hallym University Medical Center|Jeil Pharmaceutical Co., Ltd. Esophageal Neoplasms November 2011 Phase 2
NCT00539968 Merck Sharp & Dohme Corp. Prostate Cancer|Breast Cancer|Ovarian Cancer|Lung Cancer|Gastric Cancer June 2007 Phase 1|Phase 2
NCT00582634 University of Wisconsin, Madison Non Small Cell Lung Cancer September 2004 Phase 2
NCT00080665 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer December 2003 Phase 1
NCT01362400 Infinity Pharmaceuticals, Inc. Non Small Cell Lung Cancer May 2011 Phase 2
NCT02274610 Samyang Biopharmaceuticals Corporation Solid Tumor November 2014 Phase 1
NCT01256359 University of Oxford Melanoma October 2010 Phase 2
NCT01741155 Spectrum Pharmaceuticals, Inc Non Small Cell Lung Cancer (NSCLC) May 2013 Phase 2
NCT00212095 National University Hospital, Singapore Metastatic Breast Cancer June 2005 Phase 2
NCT02442531 Cristal Therapeutics Cancer|Metastatic Cancer|Solid Tumors August 2015 Phase 1
NCT02024841 The University of Hong Kong|Taiho Pharmaceutical Co., Ltd. Gastric Cancer|Peritoneal Carcinomatosis December 2013 Phase 1
NCT01019941 Chong Kun Dang Pharmaceutical Advanced Solid Cancers August 2009 Phase 1
NCT00474669 James Graham Brown Cancer Center|University of Louisville Ovarian Carcinoma June 2007 Phase 1
NCT02490475 Hoffmann-La Roche Solid Tumor February 2004 Phase 1
NCT02376296 Saladax Biomedical, Inc.|UPMC CancerCenter Prostate Cancer February 2015
NCT01957007 OncoMed Pharmaceuticals, Inc. Solid Tumors September 2013 Phase 1
NCT00253318 M.D. Anderson Cancer Center|Novartis Pharmaceuticals Breast Cancer November 2005 Phase 1
NCT01825265 M.D. Anderson Cancer Center|Novartis Pharmaceuticals Breast Cancer November 2005 Phase 2
NCT00227721 Robert Morris|National Cancer Institute (NCI)|Barbara Ann Karmanos Cancer Institute Ovarian Cancer|Peritoneal Cavity Cancer February 2004 Phase 2
NCT00525005 Hallym University Medical Center|Asan Medical Center|Sanofi Stomach Neoplasms August 2007 Phase 2
NCT02547987 Mothaffar Rimawi|Baylor Breast Care Center Breast Cancer September 2015 Phase 2
NCT00123929 Hospital San Carlos, Madrid|UNC Lineberger Comprehensive Cancer Center Breast Cancer January 2005 Phase 2
NCT01685489 Bastyr University|University of Washington|Fred Hutchinson Cancer Research Center Prostatic Neoplasms May 2013 Phase 1
NCT02289378 Sixth Affiliated Hospital, Sun Yat-sen University Docetaxel, Oxaliplatin and Fluorouracil November 2014 Phase 2
NCT02378389 Jiangsu HengRui Medicine Co., Ltd. HER2 Positive Gastric Cancer September 2014 Phase 1
NCT01611961 Shenyang Pharmaceutical University Advanced Cancer August 2012 Phase 1
NCT01044485 Centre Georges Francois Leclerc|GlaxoSmithKline|Sanofi Metastatic Breast Cancer November 2008 Phase 1|Phase 2
NCT03159143 University of Pittsburgh|Sanofi-Synthelabo Metastatic Transitional Cell Cancer of the Urothelial Tract December 17, 2004 Phase 2
NCT00287885 Masonic Cancer Center, University of Minnesota Cervical Cancer|Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer|Sarcoma|Vaginal Cancer|Vulvar Cancer March 2004 Phase 1
NCT00614835 Memorial Sloan Kettering Cancer Center Uterine Leiomyosarcoma|Uterine Cancer August 2001
NCT01560663 Hospital General Universitario Gregorio Marañon|UNC Lineberger Comprehensive Cancer Center|Hospital Universitario Ramon y Cajal|Hospital San Carlos, Madrid|Centro Nacional de Investigaciones Oncologicas CARLOS III Breast Cancer|Breast Cancer Stage II-III January 2012
NCT00697437 National University Hospital, Singapore Solid Tumors October 2006 Phase 2
NCT00113347 M.D. Anderson Cancer Center|Aventis Pharmaceuticals|Genentech, Inc. Head and Neck Cancer April 2005 Phase 1
NCT00293085 Central European Cooperative Oncology Group Non-Small Cell Lung Cancer December 2001 Phase 2
NCT00496795 University of Bergen|Haukeland University Hospital Stage III Breast Cancer AJCC V7 September 2007 Phase 2
NCT03147963 Zhejiang Cancer Hospital Breast Cancer December 20, 2015 Phase 2
NCT00183872 University of Southern California|Sanofi Gastric Cancer|Esophageal Neoplasms April 14, 2005 Phase 2
NCT01312311 Samsung Medical Center Nasopharyngeal Cancer July 2006 Phase 2
NCT01183364 Synta Pharmaceuticals Corp. Solid Tumor Malignancies July 2010 Phase 1
NCT00430651 Hellenic Oncology Research Group|University Hospital of Crete Non-Small Cell Lung Cancer July 2004 Phase 3
NCT02083536 University of Miami Ovarian Cancer|Ovarian Carcinoma|Recurrent Ovarian Cancer|Recurrent Ovarian Carcinoma May 2014 Phase 1
NCT00714246 Milton S. Hershey Medical Center|Sanofi Non Small Cell Lung Cancer October 2008 Phase 1|Phase 2
NCT02504489 BeyondSpring Pharmaceuticals Inc. Non-Small Cell Lung Cancer June 2016 Phase 3
NCT03043989 Sidney Kimmel Comprehensive Cancer Center Prostate Cancer March 21, 2017 Phase 1
NCT01380275 National Cancer Center, Korea Sarcoma April 2008 Phase 2
NCT00511576 Mirati Therapeutics Inc. Breast Cancer|Lung Cancer|Pulmonary Cancer|Non-Small-Cell Lung Carcinoma|Prostate Cancer|Prostatic Cancer|Gastric Cancer|Stomach Cancer August 2007 Phase 1
NCT00983047 Biotech Pharmaceutical Co., Ltd. Advanced Non-Small Cell Lung Cancer August 2009 Phase 2
NCT00645333 University of Michigan Cancer Center|Baylor College of Medicine|Ohio State University|Dana-Farber Cancer Institute|Weill Medical College of Cornell University|Merck Sharp & Dohme Corp. Metastatic Breast Cancer March 2008 Phase 1|Phase 2
NCT01238055 Samsung Medical Center Advanced Gastric Cancer November 2008 Phase 2
NCT01071928 Hoosier Cancer Research Network|Novartis Pharmaceuticals Urothelial Carcinoma June 2010 Phase 2
NCT00684099 Hellenic Oncology Research Group|University Hospital of Crete Non Small Cell Lung Cancer May 2006 Phase 1|Phase 2
NCT00862134 Proacta, Incorporated Non-Small Cell Lung Cancer March 2009 Phase 2
NCT00052169 NSABP Foundation Inc|AstraZeneca Breast Neoplasms January 2003 Phase 2
NCT00976976 Asan Medical Center Resected Advanced Gastric Cancer May 2007 Phase 2
NCT00248560 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Head and Neck Cancer January 2005 Phase 2
NCT01660399 Tianjin Medical University Cancer Institute and Hospital Squamous Cell Lung Cancer August 2012 Phase 2
NCT00428922 Bhuvaneswari Ramaswamy|Genentech, Inc.|Case Comprehensive Cancer Center|University of Pittsburgh|Ohio State University Comprehensive Cancer Center Breast Cancer June 14, 2007 Phase 2
NCT01567163 Eli Lilly and Company Malignant Solid Tumor July 2012 Phase 2
NCT00008411 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Breast Cancer December 1999 Phase 3
NCT02639858 Samyang Biopharmaceuticals Corporation Head and Neck Squamous Cell Carcinoma October 2015 Phase 2
NCT01921673 Asan Medical Center|Novartis Pharmaceuticals Gastric Cancer August 2013 Phase 1|Phase 2
NCT00450008 The Methodist Hospital System|Bayer Prostatic Neoplasms December 2006 Phase 2
NCT00888108 Abbott|Genentech, Inc. Solid Tumor July 2009 Phase 1
NCT02364362 Jiangsu HengRui Medicine Co., Ltd.|Shanghai Pulmonary Hospital, Shanghai, China Non-Small Cell Lung Cancer (NSCLC) November 2014 Phase 1
NCT00944424 King Faisal Specialist Hospital & Research Center Breast Cancer July 2009 Phase 3
NCT00318890 University of Alabama at Birmingham|Aventis Pharmaceuticals Cancer of Head and Neck|Head Cancer|Head and Neck Cancer|Neck Cancer|Neck Neoplasms October 2002 Phase 1|Phase 2
NCT01798485 Synta Pharmaceuticals Corp. Non-Small-Cell Lung Adenocarcinoma|Non-small Cell Lung Cancer Stage IIIB|Non-small Cell Lung Cancer Stage IV|Non-small Cell Lung Cancer Metastatic April 2013 Phase 3
NCT03069937 Medical University of South Carolina|Ferring Pharmaceuticals Metastatic Prostatic Adenocarcinoma March 1, 2017 Phase 2
NCT00030420 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Lung Cancer October 2001 Phase 2
NCT01907308 University of Colorado, Denver|Amgen Urothelial Carcinoma February 2014 Phase 2
NCT02225405 M.D. Anderson Cancer Center|Boehringer Ingelheim Lung Cancer April 2015 Phase 1
NCT02346370 Halozyme Therapeutics Non-small Cell Lung Cancer November 30, 2014 Phase 1
NCT00258284 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Prostate Cancer August 2003 Phase 2
NCT01561456 Axelar AB Non-small-cell Lung Cancer|Squamous Cell Carcinoma|Adenocarcinoma of the Lung December 2011 Phase 2
NCT01442909 Taipei Veterans General Hospital, Taiwan Non-small-cell Lung Cancer March 2008 Phase 4
NCT01172028 University of Arizona|National Cancer Institute (NCI) Breast Cancer|Esophageal Cancer|Gastric Cancer|Head and Neck Cancer|Lung Cancer|Ovarian Cancer|Prostate Cancer September 2005 Phase 1
NCT02026921 Nordic Society for Gynaecologic Oncology Ovarian Epithelial Cancer Recurrent June 2004 Phase 2
NCT00075374 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer October 2003 Phase 2
NCT01755923 Peking Union Medical College Hospital Non-small Cell Lung Cancer December 2012 Phase 2
NCT00905983 Hospital Arnau de Vilanova Carcinoma, Non-Small-Cell Lung October 2007 Phase 2
NCT02718820 Medical University of Vienna Head and Neck Carcinoma March 2016 Phase 1|Phase 2
NCT02128906 University of Pittsburgh Squamous Cell Carcinoma December 2013 Phase 2
NCT01882985 University of California, Irvine Adenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate Cancer December 2010 Phase 2
NCT00048087 M.D. Anderson Cancer Center|AstraZeneca|Aventis Pharmaceuticals Non-small Cell Lung Cancer August 2002 Phase 2
NCT02137083 Fudan University Metastatic Breast Cancer April 2014 Phase 2
NCT00541099 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Lung Cancer January 2008 Phase 2
NCT00216112 Daniela Matei, MD|Novartis Pharmaceuticals|Sanofi|Walther Cancer Institute|Hoosier Cancer Research Network Ovarian Cancer December 2003 Phase 2
NCT00169520 GlaxoSmithKline Solid Tumor Cancer June 2004 Phase 1
NCT01106352 Bayer Bone Metastases|Castration-Resistant Prostate Cancer July 2010 Phase 1|Phase 2
NCT00890825 AstraZeneca Non Small Cell Lung Cancer April 2009 Phase 2
NCT00406276 Emory University Lung Cancer November 2006 Phase 1|Phase 2
NCT00741195 Hellenic Oncology Research Group Non-small-cell Lung Cancer April 2008 Phase 2
NCT00201708 Ohio State University Comprehensive Cancer Center Breast Cancer October 2004 Phase 2
NCT01540110 National Cancer Centre, Singapore Breast Cancer August 2010 Phase 2
NCT01103791 Samyang Biopharmaceuticals Corporation Advanced Solid Malignancies April 2010 Phase 1
NCT00801801 Francisco Robert,MD|Sanofi|Bayer|University of Alabama at Birmingham Non Squamous Cell Lung Cancer|Non Small Cell Lung Cancer January 2008 Phase 2
NCT00695994 National University Hospital, Singapore Non Small Cell Lung Cancer|Breast Cancer October 2006 Phase 2
NCT00880334 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital|AstraZeneca Transitional Cell Carcinoma|Bladder Cancer September 2006 Phase 2
NCT00712504 Pfizer Advanced Solid Tumors|Non Small Cell Lung Cancer July 2004 Phase 1
NCT01479036 Xijing Hospital Breast Cancer October 2011 Phase 3
NCT02110992 University of Cincinnati Head and Neck Cancer April 2014 Phase 1
NCT02793765 The University of Texas Health Science Center, Houston Prostate Cancer December 2016 Phase 2
NCT00906061 Hospital Arnau de Vilanova Carcinoma, Non-Small-Cell Lung October 2007 Phase 2
NCT00375999 Yonsei University Stomach Neoplasms September 2006 Phase 2
NCT02985021 Seattle Institute for Biomedical and Clinical Research|Prostate Cancer Foundation|VA Puget Sound Health Care System Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer November 2016 Phase 2
NCT00514540 M.D. Anderson Cancer Center Prostate Cancer May 2006 Phase 2
NCT00565227 University of Michigan Cancer Center Non-Small-Cell Lung Carcinoma|Prostate Cancer|Bladder Cancer|Urothelial Carcinoma April 2007 Phase 1
NCT00041093 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Recurrent Cervical Carcinoma June 2002 Phase 2
NCT00669162 University of Kansas Medical Center Prostate Cancer August 2012 Phase 1|Phase 2
NCT01876251 Pfizer Breast Cancer Metastatic November 2013 Phase 1
NCT02027376 Spanish Breast Cancer Research Group|Novartis Advanced Breast Cancer May 2014 Phase 1
NCT00883675 Michael Mann|Sanofi|Maestro Clinical, Inc. Non-small Cell Lung Cancer May 2009 Phase 4
NCT01658462 Centre Oscar Lambret|Boehringer Ingelheim Breast Cancer May 2013 Phase 2
NCT01773785 Spectrum Pharmaceuticals, Inc Biliary Cancer April 2013 Phase 2
NCT01019798 Taipei Medical University Hospital|Pfizer|TTY Biopharm Non Small Cell Lung Cancer January 2009 Phase 2
NCT00172380 National Taiwan University Hospital NSCLC February 2005 Phase 2
NCT00664170 Mast Therapeutics, Inc. Advanced Cancer April 2008 Phase 1
NCT02776137 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Head-and-neck Cancer|Squamous Cell Carcinoma June 2016 Phase 2
NCT00103389 Medigen Biotechnology Corporation|Progen Pharmaceuticals Lung Cancer February 2004 Phase 2
NCT00485485 M.D. Anderson Cancer Center|Novartis Head and Neck Cancer|Squamous Cell Cancer January 2007 Phase 2
NCT00321646 Mary-Ellen Taplin, MD|Beth Israel Deaconess Medical Center|Duke University|Genentech, Inc.|Sanofi|Dana-Farber Cancer Institute Prostate Cancer|Adenocarcinoma of the Prostate June 2006 Phase 2
NCT01652469 European Thoracic Oncology Platform|Biodesix Inc. Carcinoma, Non-Small-Cell Lung August 2012 Phase 3
NCT00137761 Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital Metastatic Pancreatic Carcinoma October 2004 Phase 2
NCT00280735 UNC Lineberger Comprehensive Cancer Center|Aventis Pharmaceuticals Lung Cancer May 2004 Phase 2
NCT01469598 Samsung Medical Center Metastatic Carcinoma|Recurrent Esophageal Squamous Cell Carcinoma August 2011 Phase 2
NCT01083589 M.D. Anderson Cancer Center|Novartis Non-small Cell Lung Cancer January 2005 Phase 2
NCT02793219 The University of Texas Health Science Center, Houston Prostate Cancer December 2016 Phase 2
NCT02451865 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer June 2016 Phase 1
NCT03041181 Greg Durm, MD|Hoosier Cancer Research Network|Bristol-Myers Squibb Non-Squamous Non-Small Cell Lung Cancer (NSCLC)|Adenocarcinoma of the Lung|Lung Cancer January 27, 2017 Phase 2
NCT02358473 Kyowa Kirin Pharmaceutical Development, Inc. Non-Small Cell Lung Cancer January 2015 Phase 1
NCT01336582 Samyang Biopharmaceuticals Corporation Solid Tumor August 2009 Phase 1
NCT00653848 Scandinavian Prostate Cancer Group|Sanofi Prostate Cancer May 2007 Phase 3
NCT01204099 Cascadian Therapeutics Inc. Non Small Cell Lung Cancer (NSCLC)|Squamous Cell Carcinoma of the Head and Neck (SCCHN) September 2010 Phase 1|Phase 2
NCT00209079 Emory University|Novartis Gastric Adenocarcinoma September 2004 Phase 2
NCT03127319 Affiliated Hospital of Hebei University Non-squamous Non-small Cell Lung Cancer May 2017 Phase 2
NCT00193037 SCRI Development Innovations, LLC|Ortho Biotech, Inc.|Aventis Pharmaceuticals Breast Cancer February 2001 Phase 2
NCT00755157 University Hospital of Crete Small Cell Lung Cancer April 2008 Phase 2
NCT01054313 M.D. Anderson Cancer Center Advanced Cancer January 2010 Phase 1
NCT00805012 Seoul National University Hospital|Clinical Research Center for Solid Tumor, Korea Head and Neck Squamous Cell Carcinoma December 2008 Phase 2
NCT00137436 Pfizer Prostatic Neoplasms October 2005 Phase 1|Phase 2
NCT02448290 Samsung Medical Center Gastric Adenocarcinoma November 12, 2014 Phase 2
NCT00047255 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer May 2002 Phase 3
NCT01935778 Asan Medical Center Gastric Cancer, Adjuvant Chemotherapy, XO September 2013 Phase 3
NCT02252913 Hutchison Medipharma Limited|AstraZeneca Gastric Cancer September 2014 Phase 1
NCT00511446 Martin-Luther-Universität Halle-Wittenberg Stomach Neoplasms August 2007 Phase 2
NCT02691871 Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Jiangsu HengRui Medicine Co., Ltd. Lung Adenocarcinoma February 2016 Phase 1
NCT00482274 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Prostate Cancer May 2007 Phase 2
NCT01418001 Memorial Sloan Kettering Cancer Center|National Comprehensive Cancer Network|University of California, Los Angeles|Washington University School of Medicine|Northwestern University Sarcoma|Leiomyosarcoma|Malignant Peripheral Nerve Sheath Tumor|Malignant Fibrous|Histiocytoma/Undifferentiated Pleomorphic Sarcoma August 2011 Phase 1|Phase 2
NCT00582582 University of Wisconsin, Madison|Sanofi|Genzyme, a Sanofi Company Prostate Cancer April 2002 Phase 2
NCT01076335 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Prostate Cancer May 2005 Phase 2
NCT01711112 Samsung Medical Center Bladder Cancer August 2010 Phase 2
NCT01705483 Astellas Pharma Global Development, Inc.|Astellas Pharma Inc Pharmacokinetics of ASP9853|Non-hematologic Malignancies August 2012 Phase 1
NCT00290693 University of Miami Pancreatic Cancer June 2004 Phase 2
NCT00390429 University of California, Davis|National Cancer Institute (NCI)|Genentech, Inc.|Aventis Pharmaceuticals Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific July 2002 Phase 1|Phase 2
NCT02775006 The Netherlands Cancer Institute|Dutch Society of Physicians for Pulmonology and Tuberculosis Carcinoma, Non-small Cell Lung May 2016 Phase 3
NCT00728663 Swiss Group for Clinical Cancer Research Prostate Cancer June 2008 Phase 2
NCT00372424 Pfizer Breast Cancer December 2006 Phase 1
NCT00080678 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Metastatic Cancer|Prostate Cancer May 2003 Phase 2
NCT00980382 National Cancer Center, Korea Stomach Neoplasms September 2004 Phase 1|Phase 2
NCT00431054 M.D. Anderson Cancer Center|Keryx Biopharmaceuticals Ovarian Cancer February 2007 Phase 1
NCT00805194 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung December 3, 2008 Phase 3
NCT00521274 The Methodist Hospital System|Oxford BioMedica Prostatic Neoplasms August 2007 Phase 2
NCT00148070 University of Michigan Cancer Center|Aventis Pharmaceuticals|Rhone-Poulenc Rorer Metastatic Breast Cancer March 1999 Phase 2
NCT00861471 New York University School of Medicine|Novartis Prostate Cancer|Prostatic Neoplasms May 2005 Phase 1|Phase 2
NCT01747707 Chinese Academy of Medical Sciences Gastric Cancer|Gastroesophageal Junction Cancer September 2012 Phase 2
NCT00088907 National Cancer Institute (NCI) Recurrent Head and Neck Cancer|Metastatic Head and Neck Cancer August 2004 Phase 3
NCT00982436 University of Vermont Head and Neck Neoplasms September 2009 Phase 1|Phase 2
NCT01446731 Inge Marie Svane|Herlev Hospital Prostatic Neoplasms October 2011 Phase 2
NCT00504257 H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|Genentech, Inc.|Sanofi Fallopian Tube Cancer|Ovarian Cancer|Malignant Tumor of Peritoneum March 2007 Phase 2
NCT02973789 NovoCure Ltd. Nonsmall Cell Lung Cancer December 2016 Phase 3
NCT00587145 National Cancer Center, Korea Stomach Neoplasms May 2006 Phase 2
NCT00390416 Memorial Sloan Kettering Cancer Center|Sanofi|Genentech, Inc. Stomach Neoplasms|Esophageal Neoplasms October 2006 Phase 2
NCT00268918 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital Ovarian Cancer|Endometrial Cancer|Cervical Cancer|Fallopian Tube Cancer|Peritoneal Cancer|Breast Cancer September 2005 Phase 1
NCT02041351 Centro Universitario contra el Cáncer Metastatic Breast Cancer November 2013 Phase 2
NCT00692900 University of Pittsburgh|Sanofi Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer December 2008 Phase 1
NCT01351597 Korean Breast Cancer Study Group Recurrent Breast Cancer|Metastatic Breast Cancer April 2011 Phase 2
NCT00975767 Mirati Therapeutics Inc. Advanced Malignancies, Non-small Cell Lung Cancer August 2009 Phase 1
NCT00025493 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer October 2001 Phase 2
NCT01905657 Merck Sharp & Dohme Corp. Non Small Cell Lung Cancer (NSCLC) August 9, 2013 Phase 2|Phase 3
NCT00193180 SCRI Development Innovations, LLC|Novartis|Aventis Pharmaceuticals Breast Cancer May 2005 Phase 2
NCT00574769 University of Southern California|Novartis|Genentech, Inc. Prostate Cancer February 17, 2010 Phase 1|Phase 2
NCT00647426 Abramson Cancer Center of the University of Pennsylvania Non-Small Cell Lung Cancer November 2007 Phase 2
NCT00517829 US Oncology Research|ImClone LLC|Sanofi Gastric Cancer Adenocarcinoma Metastatic July 2007 Phase 2
NCT00811031 M.D. Anderson Cancer Center|Sanofi Prostate Cancer Phase 2
NCT01803503 National University Hospital, Singapore Solid Tumors|Breast Cancer|Non-small Cell Lung Cancer|Prostate Cancer|Gastric Cancer May 2013 Phase 2
NCT02574598 Instituto Nacional de Cancerologia de Mexico Carcinoma, Non-Small-Cell Lung June 2016 Phase 2
NCT03137004 Fujian Cancer Hospital Advanced Gastric Cancer June 1, 2017 Phase 2
NCT02813785 Hoffmann-La Roche Non-Small Cell Lung Cancer July 31, 2016 Phase 3
NCT00400205 Emory University|Sanofi Squamous Cell Carcinoma|Oral Cancer August 2006 Phase 2
NCT00870714 Kansas City Veteran Affairs Medical Center|Sanofi Prostate Cancer September 2004
NCT00201812 Ohio State University Comprehensive Cancer Center|Immunex Corporation Tumors November 2000 Phase 1
NCT00697060 AmpliMed Corporation Carcinoma, Non-Small-Cell Lung August 2010 Phase 2
NCT00042939 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Pancreatic Cancer July 2003 Phase 2
NCT00003565 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Bladder Cancer|Breast Cancer|Head and Neck Cancer|Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific September 1998 Phase 2
NCT00354601 Wake Forest University Health Sciences|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer January 2006 Phase 2
NCT00876460 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung March 2009 Phase 1
NCT00348816 The University of Texas Health Science Center at San Antonio Prostate Cancer May 2006 Phase 2
NCT00209729 Hokkaido Gastrointestinal Cancer Study Group|Hokkaido University Hospital Gastric Cancer April 2005 Phase 1|Phase 2
NCT01780545 Noah Hahn, M.D.|OncoGenex Technologies|Hoosier Cancer Research Network Bladder Cancer|Urothelial Carcinoma April 2013 Phase 2
NCT00287768 Japan Clinical Cancer Research Organization|Korean Cancer Study Group Gastric Cancer March 2006 Phase 3
NCT00331682 National Cancer Institute (NCI) Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer March 2006 Phase 2
NCT02972216 Yung Shin Pharm. Ind. Co., Ltd.|Taichung Veterans General Hospital|National Cheng-Kung University Hospital|Tri-Service General Hospital Nonsmall Cell Lung Cancer|Squamous Cell Carcinoma of the Head and Neck November 2014 Phase 4
NCT02144194 Cancer Research Group - Collaborative Group, Beirut, Lebanon. Breast Cancer March 2012 Phase 2
NCT00231465 H. Lee Moffitt Cancer Center and Research Institute|AstraZeneca Non-Small Cell Lung Cancer July 2003 Phase 2
NCT01352494 Korean Breast Cancer Study Group Breast Cancer Stage II|Breast Cancer Stage III May 2011 Phase 2
NCT02922777 University of Texas Southwestern Medical Center|Texas Tech University Health Sciences Center|BerGenBio ASA Non-Small Cell Lung Carcinoma November 2016 Phase 1
NCT00584012 University of Iowa Any Cancer|Breast Cancer April 2004 Phase 1|Phase 2
NCT02057107 University of Pittsburgh Recurrent|Head and Neck Cancer May 2013 Phase 2
NCT00426127 University of Iowa|Aventis Pharmaceuticals Pancreatic Cancer November 2006 Phase 2
NCT00076310 M.D. Anderson Cancer Center|Aventis Pharmaceuticals|Genentech, Inc. Head and Neck Cancer January 2004 Phase 2
NCT00021242 Children's Oncology Group|National Cancer Institute (NCI) Leukemia August 2002 Phase 2
NCT00678626 Pfizer Breast Cancer April 2009 Phase 2
NCT00091442 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Breast Cancer September 2004 Phase 3
NCT02780778 Tianjin Medical University Cancer Institute and Hospital Non-small Cell Lung Cancer May 2016 Phase 2|Phase 3
NCT02779608 Fudan University Stomach Neoplasms|Peritoneal Metastasis January 20, 2017 Phase 2
NCT00217672 Translational Oncology Research International|National Cancer Institute (NCI)|University of California, Los Angeles Breast Cancer May 2005 Phase 2
NCT00327288 AmpliMed Corporation Non-small Cell Lung Cancer|Breast Cancer|Prostate Cancer October 2005 Phase 1
NCT00059943 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Breast Cancer|Lung Cancer|Prostate Cancer September 2002 Phase 2
NCT00069160 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Lung Neoplasms|Ovarian Neoplasms|Cervix Neoplasms|Renal Neoplasms September 2003 Phase 2
NCT02884479 SciClone Pharmaceuticals International (Cayman) Development Limited|Parexel|National Cheng-Kung University Hospital|SciClone Pharmaceuticals Advanced Solid Tumor|Non-Small Cell Lung Cancer August 2016 Phase 1|Phase 2
NCT02171676 Boehringer Ingelheim Neoplasms May 2005 Phase 1
NCT00177255 University of Pittsburgh|Aventis Pharmaceuticals|Roche Pharma AG Cancer April 2005 Phase 2
NCT00274456 Celgene Corporation Metastatic Breast Cancer November 2005 Phase 2
NCT02004769 Sun Yat-sen University|Fudan University|307 Hospital of PLA|Shandong Tumor Hospital|Tongji Hospital|West China Hospital|Shandong Provincial Hospital|Second Affiliated Hospital of Suzhou University|Tianjin Medical University General Hospital|Second Affiliated Hospital, School of Medicine, Zhejiang University|Sixth Affiliated Hospital, Sun Yat-sen University|Nanfang Hospital of Southern Medical University Stomach Neoplasms|Neoplasms Metastasis|ERBB2 Gene Amplification November 2013 Phase 2
NCT01229605 Tufts Medical Center Breast Cancer October 2010 Phase 2
NCT01671332 University of Wisconsin, Madison|Medical College of Wisconsin|Optimum Therapeutics, LLC|Ohio State University Carcinoma, Non Small Cell Lung June 2012 Phase 2
NCT01009775 Astellas Pharma Inc Melanoma November 2009 Phase 2
NCT00054275 Paula Silverman, MD|National Cancer Institute (NCI)|Case Comprehensive Cancer Center Breast Cancer December 2002 Phase 2
NCT01814150 Gottfried Maya|Meir Medical Center Metastatic Lung Cancer|Metastatic Breast Cancer|Metastatic Gastric Cancer|Metastatic Prostate Cancer|Metastatic Bladder Cancer April 2013
NCT01468532 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer October 2011 Phase 1|Phase 2
NCT00356941 Masonic Cancer Center, University of Minnesota Lung Cancer April 2006 Phase 1
NCT01999673 Peregrine Pharmaceuticals Non-Small-Cell Lung Cancer Stage IIIB|Non-Small-Cell Lung Cancer Stage IV|Non-Small-Cell Lung Cancer Metastatic|Carcinoma, Non-Small-Cell Lung|Non-Small Cell Lung Cancer|Non-Small-Cell Lung Carcinoma|Nonsmall Cell Lung Cancer December 2013 Phase 3
NCT00193024 SCRI Development Innovations, LLC|Aventis Pharmaceuticals|Pharmacia and Upjohn Breast Cancer September 2001 Phase 2
NCT01527487 SCRI Development Innovations, LLC|Eisai Inc. HER2 Negative Breast Cancer June 2012 Phase 2
NCT00313482 Veeda Oncology|Bayer Hormone Refractory Prostate Cancer April 2006 Phase 2
NCT00432315 Sanofi Carcinoma, Squamous Cell May 2001 Phase 2
NCT00217581 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer October 2004 Phase 2
NCT01619813 Canadian Cancer Trials Group|Oncolytics Biotech Prostate Cancer July 2012 Phase 2
NCT01038804 Astellas Pharma Inc Breast Cancer December 2009 Phase 2
NCT00378573 Sanofi Non-small Cell Lung Cancer January 2007 Phase 2
NCT00541281 Cliniques universitaires Saint-Luc- Université Catholique de Louvain|Sanofi Hormone Resistant Prostate Cancer|Metastatic Prostate Cancer December 2003 Phase 2
NCT00525642 Fudan University Breast Neoplasms|Adjuvant|Chemotherapy June 2003 Phase 2|Phase 3
NCT00137813 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Genentech, Inc.|Sanofi Esophageal Cancer|Gastric Cancer August 2004 Phase 2
NCT00288444 Emory University|Aventis Pharmaceuticals|Schering-Plough Lung Cancer|Soft Tissue Sarcoma|Colorectal Carcinoma|Breast Cancer|Prostate Cancer January 2006 Phase 1
NCT00571675 Ascenta Therapeutics Hormone Refractory Prostate Cancer October 2007 Phase 2
NCT00479089 M.D. Anderson Cancer Center|AstraZeneca Bladder Cancer February 2004 Phase 2
NCT01836120 Hebei Tumor Hospital Gastric Cancer April 2013 Phase 2
NCT00754351 University Hospital of Crete Breast Cancer September 2008 Phase 2
NCT00285415 Carilion Clinic|Sanofi Advanced Endometrial Adenocarcinoma, Stage III A, B, C April 2005 Phase 2
NCT00258765 Novartis Pharmaceuticals|Novartis Prostate Cancer May 2006 Phase 2
NCT00132639 Haruhiko Fukuda|Ministry of Health, Labour and Welfare, Japan|Japan Clinical Oncology Group Pulmonary Neoplasms October 2002 Phase 2
NCT00377559 Catharina Ziekenhuis Eindhoven|Cephalon|Sanofi Breast Cancer|Neoplasm Metastasis May 2006 Phase 2
NCT02531737 University Hospital, Limoges|Boehringer Ingelheim Lung Neoplasms September 2015 Phase 2
NCT02134990 Oshadi Drug Administration Carcinoma, Non-Small-Cell Lung June 2014 Phase 2
NCT00216138 Hoosier Cancer Research Network|Sanofi|Hoffmann-La Roche|Walther Cancer Institute Head and Neck Cancer March 2004 Phase 2
NCT00565448 Sanofi Nasopharyngeal Neoplasms|Carcinoma November 2007 Phase 2
NCT01824901 ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer September 2013 Phase 1|Phase 2
NCT00617669 AstraZeneca Prostate Cancer January 2008 Phase 3
NCT00452556 Nova Scotia Cancer Centre Prostatic Neoplasms May 2007 Phase 2
NCT01777945 Hoffmann-La Roche Breast Cancer December 2012
NCT02766140 Jiangsu HengRui Medicine Co., Ltd.|Shanghai Pulmonary Hospital, Shanghai, China Non Squamous Non Small Cell Lung June 2016 Phase 3
NCT02864394 Merck Sharp & Dohme Corp. Carcinoma, Non-Small-Cell Lung September 7, 2016 Phase 3
NCT00153881 Dartmouth-Hitchcock Medical Center|Sanofi|Hoffmann-La Roche Esophageal Neoplasms February 2000 Phase 1
NCT00621049 SCRI Development Innovations, LLC|Genentech, Inc.|Sanofi Non-Small Cell Lung Cancer December 2007 Phase 2
NCT01350817 University Hospital, Limoges|Hoffmann-La Roche Non Small Cell Lung Cancer May 2011 Phase 2
NCT00439270 Bristol-Myers Squibb Metastatic Prostate Cancer July 2007 Phase 1|Phase 2
NCT00484666 Carilion Clinic|GlaxoSmithKline Ovarian Cancer May 2008 Phase 2
NCT00543829 German Breast Group Breast Neoplasms April 1998 Phase 2
NCT02127372 Duke University Non-small Cell Lung Cancer November 2004 Phase 1|Phase 2
NCT00532441 Gabi Chiorean, MD|Sanofi|OSI Pharmaceuticals|Hoosier Cancer Research Network Hepatocellular Carcinoma September 2007 Phase 2
NCT00577356 Benaroya Research Institute|Cell Genesys|Sanofi Prostate Cancer February 2008 Phase 2
NCT00354562 Abbott Lung Cancer|Non-Small Cell Lung Cancer February 2007 Phase 1|Phase 2
NCT00087035 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Prostate Cancer May 2004 Phase 2
NCT00916123 Weill Medical College of Cornell University Prostate Cancer May 2009 Phase 1
NCT00134056 Southwest Oncology Group|National Cancer Institute (NCI) Metastatic Cancer|Prostate Cancer August 2006 Phase 3
NCT01907685 Sanofi Advanced Neoplastic Disease June 2006 Phase 1
NCT01673867 Bristol-Myers Squibb Non-Squamous Cell Non-small Cell Lung Cancer October 2012 Phase 3
NCT00080626 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer July 2003 Phase 2
NCT01348126 Synta Pharmaceuticals Corp. Non-small Cell Lung Cancer Stage IIIB|Non-small Cell Lung Cancer Stage IV|Non-small Cell Lung Cancer Metastatic May 2011 Phase 2|Phase 3
NCT00179309 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer September 2005 Phase 2
NCT00524810 ARCAGY/ GINECO GROUP Metastatic Breast Cancer February 2004 Phase 2
NCT01653158 Pfizer Advanced Non-Hematologic Malignancies March 2005 Phase 1
NCT00074022 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Recurrent Prostate Cancer|Stage III Prostate Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer|Stage IV Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific October 2003 Phase 1|Phase 2
NCT00675597 Memorial Sloan Kettering Cancer Center|Sanofi Lung Cancer May 2008
NCT00915850 Wakayama Medical University Esophageal Cancer August 2007 Phase 1|Phase 2
NCT00256282 University of California, Irvine|Bayer Metastatic Melanoma April 2003 Phase 2
NCT00669370 University of Turku|Sanofi Stomach Neoplasms June 2006 Phase 2
NCT00324012 Rigshospitalet, Denmark Adrenocortical Carcinoma April 2006 Phase 2
NCT00166881 National Taiwan University Hospital|Far Eastern Memorial Hospital Gastric Cancer June 2000 Phase 2
NCT01485926 Cancer Trials Ireland Breast Cancer October 2010 Phase 2
NCT01148615 Sanofi|Regeneron Pharmaceuticals Neoplasm Malignant July 2010 Phase 1
NCT02959749 Qingdao Central Hospital Progression Free Survival August 2015 Phase 2|Phase 3
NCT01642004 Bristol-Myers Squibb Squamous Cell Non-small Cell Lung Cancer September 2012 Phase 3
NCT00598858 John P. Fruehauf|Sanofi|University of California, Irvine Prostate Cancer|Adenocarcinoma of the Prostate|Stage I Prostate Cancer|Stage II Prostate Cancer January 2009 Phase 2
NCT00661778 Hoffmann-La Roche Non-small Cell Lung Cancer July 2007 Phase 2
NCT00783471 Hellenic Cooperative Oncology Group Advanced Non-Small Cell Lung Cancer November 2008 Phase 2
NCT00049296 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Cancer July 2002 Phase 1
NCT00619996 Italian Trial in Medical Oncology Prostate Cancer March 2007 Phase 2
NCT02565901 University of Washington|National Cancer Institute (NCI) Castration Levels of Testosterone|Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Prostate Carcinoma Metastatic in the Bone|PSA Progression|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer February 2016 Phase 1|Phase 2
NCT00845884 Rabin Medical Center Advanced Gastric Cancer February 2009 Phase 1|Phase 2
NCT00357747 NCIC Clinical Trials Group|Canadian Cancer Trials Group Unspecified Adult Solid Tumor, Protocol Specific April 2005 Phase 1
NCT00198237 Indiana University School of Medicine|Aventis Pharmaceuticals|Indiana University Breast Cancer March 2003 Phase 2
NCT01107444 Eli Lilly and Company Non Small Cell Lung Cancer May 2010 Phase 2
NCT00049088 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific August 2002 Phase 1
NCT02524275 University of Nebraska|National Cancer Institute (NCI) Head and Neck Squamous Cell Carcinoma March 2015 Phase 2
NCT00551577 University Hospital, Bonn|Sanofi Ovarian Neoplasms March 2003 Phase 2
NCT02536495 Erin Bertino|Karyopharm Therapeutics Inc|Ohio State University Comprehensive Cancer Center Recurrent Squamous Cell Lung Carcinoma|Stage IV Squamous Cell Lung Carcinoma September 2015 Phase 1|Phase 2
NCT00142571 Memorial Sloan Kettering Cancer Center|Connective Tissue Oncology Society|M.D. Anderson Cancer Center|Massachusetts General Hospital|Mayo Clinic|University of Michigan Cancer Center Sarcoma, Soft Tissue January 2003 Phase 3
NCT00840125 Meir Medical Center Non-Small Cell Lung Cancer February 2009 Phase 2
NCT00461344 Sanofi Ductal Carcinoma July 2004 Phase 2
NCT01094288 Millennium Pharmaceuticals, Inc.|Takeda Advanced Solid Tumors|Adenocarcinoma of the Prostate September 2010 Phase 1
NCT01084655 Millennium Pharmaceuticals, Inc. Prostate Cancer July 2010 Phase 1|Phase 2
NCT00072033 Swiss Group for Clinical Cancer Research Esophageal Cancer March 2003 Phase 2
NCT00979641 Tampere University Hospital|Oulu University Hospital|Turku University Hospital Neoplasms January 2009 Phase 2
NCT02658747 Hoffmann-La Roche Non-Small Cell Lung Cancer May 25, 2016
NCT00707473 M.D. Anderson Cancer Center Paranasal Sinus Neoplasms|Squamous Cell Carcinoma June 2008 Phase 2
NCT00271505 M.D. Anderson Cancer Center|Genentech, Inc. Non-Small Cell Lung Cancer December 2005 Phase 2
NCT00253370 National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Metastatic Gastric Cancer|Advanced Unresectable Gastric Cancer October 2005 Phase 2
NCT00679341 Hoffmann-La Roche Breast Cancer September 2008 Phase 2
NCT00276055 New Mexico Cancer Care Alliance Sarcoma November 2005 Phase 1
NCT00066456 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Carcinoma|Primary Peritoneal Carcinoma|Recurrent Ovarian Carcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer September 2003 Phase 1
NCT00145418 Oncology Specialists, S.C.|Sanofi-Synthelabo Carcinoma, Non-Small-Cell Lung February 2005 Phase 2
NCT00526110 M.D. Anderson Cancer Center|Sanofi-Synthelabo Gastrointestinal Diseases August 2004 Phase 1|Phase 2
NCT00786682 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Prostate Cancer December 2008 Phase 2
NCT00065182 GlaxoSmithKline Non-Small-Cell Lung Cancer|Lung Cancer, Non-Small Cell August 2003 Phase 2
NCT02598895 University of Washington|National Cancer Institute (NCI) Castration Levels of Testosterone|Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Prostate Carcinoma Metastatic in the Bone|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer January 2016
NCT02643407 Guangdong Association of Clinical Trials Non-Small Cell Lung Cancer October 2015 Phase 3
NCT01126008 Samsung Medical Center Head and Neck Cancer December 2009 Phase 2
NCT00441922 Hellenic Oncology Research Group|University Hospital of Crete Non Small Cell Lung Cancer January 2003 Phase 3
NCT01206036 Central European Society for Anticancer Drug Research Prostatic Neoplasms July 2010 Phase 1|Phase 2
NCT00206518 Mothaffar Rimawi|Baylor College of Medicine|Baylor Breast Care Center Breast Cancer September 2004 Phase 2
NCT00687440 Merck Sharp & Dohme Corp.|MDS Pharma Services Breast Neoplasm May 18, 2005 Phase 2
NCT03093272 Dana-Farber Cancer Institute|Janssen Pharmaceutica Prostate Cancer April 2017 Phase 2
NCT00448734 Poniard Pharmaceuticals Hormone Refractory Prostate Cancer June 2006 Phase 1|Phase 2
NCT00118131 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Aventis Pharmaceuticals|Rutgers, The State University of New Jersey Lung Cancer December 2003 Phase 2
NCT00980603 National Cancer Center, Korea|Seoul National University Bundang Hospital|Chungbuk National University Hospital|Gachon University Gil Medical Center Gastric Cancer November 2008 Phase 2
NCT00544960 Ascenta Therapeutics Non-small Cell Lung Cancer September 2007 Phase 2
NCT00908336 Hospital Arnau de Vilanova Non-Small Cell Lung Cancer March 2009 Phase 2
NCT00686985 Jeroen Bosch Ziekenhuis Small Cell Lung Cancer September 2007 Phase 2
NCT00085358 National Cancer Institute (NCI) Brenner Tumor|Fallopian Tube Cancer|Ovarian Carcinosarcoma|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Primary Peritoneal Cavity Cancer|Stage II Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer May 2004 Phase 1
NCT01621425 Radboud University Breast Cancer|Metastatic Castration-resistant Prostate Carcinoma June 2012
NCT00276549 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Prostate Cancer October 2005 Phase 2
NCT02649855 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Prostate Cancer|Prostate Neoplasms|Neoplasms, Prostatic January 4, 2016 Phase 2
NCT02787473 First People's Hospital of Hangzhou Squamous Cell Lung Cancer October 2016 Phase 2
NCT01234051 Korean South West Oncology Group Biliary Tract Cancer November 2010 Phase 2
NCT02191059 Shandong Cancer Hospital and Institute Non Small Cell Lung Cancer July 2014 Phase 2
NCT02036359 National Taiwan University Hospital Non-small Cell Lung Cancer(NSCLC) May 2012 Phase 2
NCT00758732 Hellenic Oncology Research Group|University Hospital of Crete Ovarian Cancer October 2005 Phase 2
NCT01932580 McGill University Gastric Adenocarcinoma|Esophageal Adenocarcinoma August 2013 Phase 2
NCT03154983 Zhou Fuxiang|Zhongnan Hospital Metastatic Gastric Cancer May 20, 2017 Phase 2
NCT00139269 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Sanofi Advanced Squamous Cell Carcinoma|Squamous Cell Carcinoma of Head and Neck|SSCHN February 1998 Phase 1|Phase 2
NCT00183794 University of Southern California|Aventis Pharmaceuticals|Eli Lilly and Company Ovarian Carcinoma|Peritoneal Neoplasms November 2002 Phase 2
NCT00301808 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Lung Cancer November 2005 Phase 2
NCT02642042 National Cancer Institute (NCI) KRAS Gene Mutation|Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer July 18, 2016 Phase 2
NCT01283217 Yonsei University Gastric Adenocarcinoma March 2010 Phase 3
NCT01718353 Sanofi Prostate Cancer Metastatic March 2013 Phase 2
NCT00312377 Genzyme, a Sanofi Company|Sanofi Non-small Cell Lung Cancer|Lung Cancer May 2006 Phase 3
NCT00941330 Emory University|Pfizer Breast Cancer July 2009 Phase 2
NCT00988208 Celgene Prostate Cancer November 11, 2009 Phase 3
NCT01025349 Taipei Medical University Hospital Metastatic Breast Cancer January 2005 Phase 2
NCT01933932 AstraZeneca Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV September 2013 Phase 3
NCT01356303 National Guard Health Affairs Non-small Cell Lung Cancer Metastatic March 2009 Phase 2
NCT02146222 University of Wisconsin, Madison|Tyrogenex|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 2014 Phase 1
NCT00343239 Sanofi Stomach Neoplasms June 2006 Phase 2
NCT00364611 Sanofi Breast Cancer August 2006 Phase 2
NCT01957995 University of Southern California|Jina Pharmaceuticals, Inc.|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific November 8, 2013 Phase 1
NCT02522910 Yonsei University NSCLC (Non-Small Cell Lung Cancer) August 2015 Phase 1|Phase 2
NCT00382720 Sanofi Stomach Neoplasms September 2006 Phase 2
NCT00587431 Memorial Sloan Kettering Cancer Center Prostate Cancer July 2003 Phase 2
NCT01938456 GlaxoSmithKline Lung Cancer, Non-Small Cell October 2013 Phase 1
NCT01903993 Hoffmann-La Roche Non-Small Cell Lung Cancer August 5, 2013 Phase 2
NCT01138163 Peregrine Pharmaceuticals Non-small-cell Lung Cancer June 2010 Phase 2
NCT00084825 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Metastatic Cancer|Prostate Cancer May 2003 Phase 2
NCT01646125 Novartis Pharmaceuticals|Novartis Advanced Non Small Cell Lung Cancer (NSCLC) November 2012 Phase 2
NCT00320749 Tony Bekaii-Saab|University of Michigan Cancer Center|Ohio State University Comprehensive Cancer Center Pancreatic Cancer December 2005 Phase 1
NCT00225420 UNC Lineberger Comprehensive Cancer Center|Sanofi Prostate Cancer August 2005 Phase 1|Phase 2
NCT00912444 Shanghai Jiao Tong University School of Medicine Breast Cancer July 2009 Phase 3
NCT00887809 Memorial Sloan Kettering Cancer Center|Genentech, Inc. Sarcoma|Leiomyosarcoma|Malignant Fibrous|Histiocytoma|Angiosarcoma April 2009 Phase 2
NCT00076388 AstraZeneca Non-Small-Cell Lung Carcinoma February 2004 Phase 3
NCT00079118 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer April 2004 Phase 2
NCT03071042 Sir Run Run Shaw Hospital|Jiangsu HengRui Medicine Co., Ltd. Metastatic Gastric Adenocarcinoma October 2015 Phase 1
NCT00500110 M.D. Anderson Cancer Center|Novartis Pharmaceuticals Prostate Cancer June 2003 Phase 2
NCT00436501 National Cancer Institute (NCI) Fallopian Tube Cancer|Malignant Tumor of Peritoneum|Recurrent Ovarian Epithelial Cancer January 2007 Phase 1|Phase 2
NCT00689156 Danish Breast Cancer Cooperative Group|Fonden Til Fremme af Klinisk- Eksperimentel Cancerforskning|Sanofi|Dako Breast Neoplasms June 2008 Phase 3
NCT01379807 Grupo Gallego de Investigaciones Oncologicas|Amgen|Trial Form Support S.L. Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma December 2010 Phase 2
NCT00286793 Ascenta Therapeutics Prostate Cancer February 2006 Phase 1|Phase 2
NCT02360501 Sun Yat-sen University Nasopharyngeal Neoplasms January 2008 Phase 2
NCT00114218 Gynecologic Oncology Group|National Cancer Institute (NCI) Recurrent Uterine Corpus Sarcoma|Uterine Carcinosarcoma March 2005 Phase 2
NCT02469116 Washington University School of Medicine|Sanofi Ovarian Cancer January 2006 Phase 2
NCT00669591 Peregrine Pharmaceuticals Breast Cancer January 2008 Phase 2
NCT00996333 Columbia University|Sanofi Metastatic Pancreatic Cancer June 2003 Phase 2
NCT00459186 Dana-Farber Cancer Institute|Novartis|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Oregon Health and Science University Metastatic, Androgen Independent Prostate Cancer|Prostate Cancer November 2005 Phase 1|Phase 2
NCT02300298 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung December 2014 Phase 1
NCT00074204 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer October 2003 Phase 3
NCT00713219 Memorial Sloan Kettering Cancer Center|Oncology/Hematology West Head and Neck Cancer July 2008 Phase 2
NCT00215709 Geriatric Oncology Consortium|Sanofi Prostate Cancer July 2004 Phase 1
NCT02007148 International Group of Endovascular Oncology Gastric Adenocarcinoma,|Gastroesophageal-junction Adenocarcinoma November 2013 Phase 2
NCT02831491 Eli Lilly and Company Stage IV Non-small Cell Lung Cancer November 2016 Phase 2
NCT00005963 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer November 2000 Phase 2
NCT02596256 Chinese PLA General Hospital Gastric Cancer April 2016 Phase 2
NCT00819728 Sanofi Carcinoma, Non-Small-Cell Lung June 2000 Phase 2
NCT00116142 Dana-Farber Cancer Institute|Sanofi Prostate Cancer June 2005 Phase 3
NCT00312208 Sanofi|Cancer International Research Group (CIRG) Breast Cancer November 2001 Phase 3
NCT02393209 Millennium Pharmaceuticals, Inc.|Takeda Non-small Cell Lung Cancer June 2015 Phase 1|Phase 2
NCT02179567 Hellenic Oncology Research Group NSCLC March 2010 Phase 2
NCT00405951 Gemin X|Teva Pharmaceutical Industries Lung Cancer October 2006 Phase 1|Phase 2
NCT01279018 Rigshospitalet, Denmark Breast Neoplasms|Pain, Postoperative|Neuralgia|Lymphedema October 2010
NCT02249702 Mario Negri Institute for Pharmacological Research|PharmaMar Leiomyosarcoma April 2010 Phase 2
NCT00006010 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Liver Cancer September 2001 Phase 2
NCT00176631 Rutgers, The State University of New Jersey|National Cancer Institute (NCI) Prostate Cancer September 2007 Phase 2
NCT00054457 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer September 2003 Phase 2
NCT00738387 Novartis Pharmaceuticals|Novartis Non-Small Cell Lung Cancer December 2008 Phase 3
NCT00931008 SK Chemicals Co.,Ltd. Non-Small Cell Lung Cancer October 2009 Phase 3
NCT00268840 ARCAGY/ GINECO GROUP Pancreatic Neoplasms|Biliary Tract Neoplasms August 2001 Phase 2
NCT00533533 Samsung Medical Center Gastric Cancer January 2006 Phase 1|Phase 2
NCT00055861 National Cancer Institute (NCI) Recurrent Breast Cancer|Stage IV Breast Cancer July 2002 Phase 2
NCT01245543 Daiichi Sankyo Inc. Solid Tumors November 2010 Phase 1
NCT00494338 Sanofi Metastatic Prostate Cancer November 2004 Phase 2
NCT01087580 Northwestern University|Genzyme, a Sanofi Company PROSTATE CANCER March 2011 Phase 2
NCT00134706 Dana-Farber Cancer Institute|Bristol-Myers Squibb|Beth Israel Deaconess Medical Center|Lowell General Hospital|Massachusetts General Hospital|Oregon Health and Science University|Wentworth-Douglass Hospital Prostate Cancer January 2004 Phase 2
NCT00125411 Agennix Tumors March 2007 Phase 1
NCT00214864 Cancer Research Network|Hoffmann-La Roche Metastatic Breast Cancer December 2002 Phase 2
NCT01577654 Endocyte Non Small Cell Lung Cancer March 2011 Phase 2
NCT00401323 Sanofi Head and Neck Neoplasms|Neoplasm Recurrence, Local|Neoplasm Metastasis January 1998 Phase 2|Phase 3
NCT00378404 Susanne Arnold|Kentucky Lung Cancer Research Program|University of Kentucky Non-Small Cell Lung Cancer November 2004 Phase 1
NCT02685267 Prostate Cancer Clinical Trials Consortium|University of Chicago|Astellas Pharma Inc Prostate Cancer February 2016 Phase 2
NCT01710592 Cancer Trials Ireland Gastro Oesophageal Cancer May 2007 Phase 2
NCT00055770 National Cancer Institute (NCI) Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Salivary Gland Squamous Cell Carcinoma|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Hypopharynx|Sta October 2002 Phase 1|Phase 2
NCT00394433 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital|Genentech, Inc. Esophageal Cancer|Stomach Cancer September 2006 Phase 2
NCT02035527 Ohio State University Comprehensive Cancer Center|National Comprehensive Cancer Network Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Na April 14, 2014 Phase 1|Phase 2
NCT02445586 Hoffmann-La Roche Breast Cancer August 17, 2015 Phase 4
NCT02257619 Incyte Corporation Non-Small Cell Lung Cancer June 2014 Phase 2
NCT00705315 Hellenic Oncology Research Group Breast Cancer May 2008 Phase 1|Phase 2
NCT02549677 Ruijin Hospital Breast Neoplasms October 2015 Phase 4
NCT00401765 Centocor, Inc. Prostatic Neoplasms September 2005 Phase 1
NCT02036060 Spanish Oncology Genito-Urinary Group Metastatic Prostate Cancer February 2014 Phase 2
NCT01437449 Stanford University Head and Neck Cancer October 2011 Phase 2
NCT01378091 Columbia University|Celgene Corporation Prostate Cancer August 2005 Phase 1
NCT00084890 Wake Forest University Health Sciences|National Cancer Institute (NCI) Cervical Cancer November 2003 Phase 1
NCT01326559 Hong Kong Nasopharyngeal Cancer Study Group Limited|The University of Hong Kong|Sanofi|Merck Sharp & Dohme Corp.|Roche Pharma AG Nasopharyngeal Carcinoma June 2010 Phase 2
NCT00174655 Sanofi Breast Neoplasms June 1998 Phase 3
NCT00882310 Columbia University Pancreatic Cancer September 2006 Phase 2
NCT00251225 University of Pittsburgh|Novartis Pharmaceuticals Prostate Cancer August 2005 Phase 2
NCT03069820 Second Affiliated Hospital of Nanchang University Liver Injury, Drug-Induced February 10, 2017 Phase 4
NCT02834403 Angel Augusto Rodriguez, MD|The Methodist Hospital System Metastatic Triple Negative Breast Cancer July 2016 Phase 1
NCT00003900 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer October 1999 Phase 2
NCT01562301 M.D. Anderson Cancer Center|National Cancer Institute (NCI)|Nerium Biotechnology Chemotherapeutic Agent Toxicity|Lung Cancer June 2014 Phase 1
NCT00705822 Sanofi Prostatic Neoplasms August 2006 Phase 3
NCT00064012 University of Wisconsin, Madison|National Cancer Institute (NCI) Lung Cancer May 2003 Phase 2
NCT00242918 Benaroya Research Institute|AstraZeneca|Sanofi Prostate Cancer May 2003 Phase 2
NCT00076024 Pfizer Breast Neoplasms February 2004 Phase 1|Phase 2
NCT00521521 Sanofi Head and Neck Neoplasms July 2001 Phase 2
NCT00688740 Sanofi|Cancer International Research Group (CIRG) Breast Cancer June 1997 Phase 3
NCT00268593 Progen Pharmaceuticals|Northern Sydney and Central Coast Area Health Service|Aventis Pharmaceuticals Prostate Cancer August 2005 Phase 2
NCT01282151 Chonnam National University Hospital|Sanofi Carcinoma, Non Small Cell Lung July 2011 Phase 3
NCT01250717 Beth Israel Deaconess Medical Center|Walter Reed Army Medical Center|Dana-Farber Cancer Institute Prostate Cancer January 2001 Phase 2
NCT00251433 Novartis Pharmaceuticals|Novartis Neoplasms, Breast September 26, 2005 Phase 1
NCT00494481 Genzyme, a Sanofi Company|Sanofi Advanced Breast Cancer January 2006 Phase 2
NCT01719302 University of Vermont|Novartis Stage III Adult Soft Tissue Sarcoma October 2012 Phase 1|Phase 2
NCT00690300 University of Ulm Pancreas Neoplasms January 2008 Phase 2
NCT00126230 Gustave Roussy, Cancer Campus, Grand Paris Prostate Cancer January 2004 Phase 2
NCT00314782 AstraZeneca Prostate Cancer March 2006 Phase 1
NCT00515411 Memorial Sloan Kettering Cancer Center|Sanofi|Roche/Genetech|City of Hope National Medical Center|Piedmont Hospital Research Institute|Medical College of Wisconsin|Queens Health Network|Weill Medical College of Cornell University|Memorial Cancer Institute, Florida|University of Pittsburgh|Long Island Jewish Medical Center|Nebraska Cancer Specialists Methodist Estabrook Cancer Center Gastroesophageal Junction Adenocarcinoma|Gastric Cancer October 2006 Phase 2
NCT01188187 OncoGenex Technologies|Teva Pharmaceutical Industries Prostate Cancer November 2010 Phase 3
NCT00703625 Washington University School of Medicine Resistant Solid Malignancies March 8, 2008 Phase 1
NCT00711243 Northwestern University|National Cancer Institute (NCI) Gastric Cancer|Unspecified Adult Solid Tumor, Protocol Specific March 2005 Phase 1|Phase 2
NCT03119857 Andreas Josefsson|Göteborg University Prostatic Neoplasms February 2009 Phase 3
NCT02516670 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Stage IV Prostate Cancer June 2016 Phase 2
NCT00238407 Swiss Group for Clinical Cancer Research Esophageal Cancer March 2004 Phase 2
NCT00362882 National Cancer Institute (NCI) Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer July 2006 Phase 2
NCT01204307 Chang Gung Memorial Hospital|Taiwan Chest Disease Association Advanced Non-Squamous Non-Small Cell Lung Cancer January 2010 Phase 2
NCT01540253 Roswell Park Cancer Institute|National Cancer Institute (NCI)|Novartis Unspecified Adult Solid Tumor, Protocol Specific May 2012 Phase 1
NCT00115635 Herlev Hospital|Sanofi|Eli Lilly and Company Prostate Cancer March 2005 Phase 1|Phase 2
NCT01932697 Mayo Clinic|National Cancer Institute (NCI) Human Papillomavirus Infection|Stage I Oropharyngeal Squamous Cell Carcinoma|Stage II Oropharyngeal Squamous Cell Carcinoma|Stage III Oropharyngeal Squamous Cell Carcinoma|Stage IVA Oropharyngeal Squamous Cell Carcinoma|Stage IVB Oropharyngeal Squamous Cell Carcinoma September 2013 Phase 2
NCT00183937 University of Southern California|Millennium Pharmaceuticals, Inc. Prostate Cancer April 2005 Phase 2
NCT01222312 Krankenhaus Nordwest Non Small Cell Lung Cancer August 2008 Phase 2
NCT00280098 Sanofi Prostatic Neoplasms January 2006 Phase 4
NCT02502864 H. Lee Moffitt Cancer Center and Research Institute|Saladax Biomedical, Inc. Breast Cancer January 26, 2016 Phase 4
NCT00073385 Titan Pharmaceuticals Carcinoma, Non-Small-Cell Lung September 2003 Phase 2
NCT01911325 Novartis Pharmaceuticals|Novartis Squamous Non-small Cell Lung Cancer October 2013 Phase 1|Phase 2
NCT01750281 AstraZeneca Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV December 2012 Phase 2
NCT00040885 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Anorexia|Cachexia|Fatigue|Lung Cancer October 2002 Phase 3
NCT01565928 Medivation, Inc.|Astellas Pharma Inc Prostate Cancer February 2012 Phase 1
NCT01015963 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Bladder Cancer|Breast Cancer|Head and Neck Cancer|Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific October 2008
NCT00006107 Dana-Farber Cancer Institute|National Cancer Institute (NCI) Head and Neck Cancer July 14, 2000 Phase 1
NCT00732745 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer October 2008 Phase 1
NCT00260026 Memorial Sloan Kettering Cancer Center Non-Small Cell Lung Cancer November 2004 Phase 2
NCT00003762 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer February 1999 Phase 2
NCT00193089 SCRI Development Innovations, LLC|Aventis Pharmaceuticals|GlaxoSmithKline Breast Cancer April 2001 Phase 2
NCT00764166 Assistance Publique - Hôpitaux de Paris|ARTIC group (oncologists and urologists association) Adenocarcinoma of the Prostate June 2003 Phase 3
NCT01268163 Hospira, now a wholly owned subsidiary of Pfizer Cancer August 2007 Phase 1
NCT01095302 Sanofi Neoplasms, Malignant May 2010 Phase 1
NCT00514917 Sanofi Prostatic Neoplasms July 2007 Phase 3
NCT03154749 Guangdong General Hospital Triple-Negative Breast Cancer September 1, 2016 Phase 2
NCT02426125 Eli Lilly and Company Urothelial Carcinoma July 2015 Phase 3
NCT00278460 Wake Forest University Health Sciences|National Cancer Institute (NCI) Lung Cancer November 2000 Phase 2
NCT03140553 Guangdong General Hospital HER2-Positive Breast Cancer September 1, 2016 Phase 2
NCT01683994 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Prostatic Neoplasms September 6, 2012 Phase 1|Phase 2
NCT02392845 Hospices Civils de Lyon Metastatic Breast Cancer June 2005 Phase 1
NCT03095612 University of Texas Southwestern Medical Center|Karyopharm Therapeutics Inc Non-small Cell Lung Cancer May 1, 2018 Phase 1|Phase 2
NCT00027885 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer November 2001 Phase 2
NCT00193050 SCRI Development Innovations, LLC|Pharmacia and Upjohn|Eli Lilly and Company|Aventis Pharmaceuticals Breast Cancer November 2001 Phase 2
NCT00227669 UNICANCER Sarcoma October 2005 Phase 2
NCT02969473 Zhu Yujia|Sun Yat-sen University Esophageal Neoplasm|Chemoradiation October 2010 Phase 2
NCT01939054 Chinese Academy of Medical Sciences|Biotech Pharmaceutical Co., Ltd. Breast Cancer September 2013 Phase 2
NCT02223884 Yonsei University Malignant Melanoma July 2011 Phase 2
NCT01285635 University of Michigan Cancer Center Squamous Cell Carcinoma of the Head and Neck (SCCHN) June 2010 Phase 2
NCT00808418 Synta Pharmaceuticals Corp. Prostate Cancer November 2008 Phase 1
NCT00088998 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer December 2004 Phase 2
NCT01567618 Sixth Affiliated Hospital, Sun Yat-sen University Gastric Adenocarcinoma March 2012 Phase 2
NCT00003200 Dana-Farber Cancer Institute|National Cancer Institute (NCI) Head and Neck Cancer October 1995 Phase 1
NCT02362620 Centro Nacional de Investigaciones Oncologicas CARLOS III Prostate Cancer|Castration Resistant|Cabacitaxel or Docetaxel May 2014
NCT01517009 Jeroen Bosch Ziekenhuis|Eindhoven Cancer Registry Gastric Cancer June 2008 Phase 2
NCT00793377 German Breast Group|German Adjuvant Breast Cancer Group Primary Breast Cancer Phase 3
NCT02439346 Bayer Medical Oncology June 15, 2015 Phase 1
NCT01703091 Eli Lilly and Company Non-small Cell Lung Cancer Metastatic December 2012 Phase 2
NCT01639131 Sidney Kimmel Comprehensive Cancer Center Metastatic Colorectal Adenocarcinoma August 2012 Phase 2
NCT02508246 University of Washington|National Cancer Institute (NCI) Head and Neck Squamous Cell Carcinoma July 22, 2015 Phase 1
NCT00232206 Providence Health & Services|Providence Cancer Center, Earle A. Chiles Research Institute|Sanofi Non-small-Cell Lung Carcinoma May 2005 Phase 2
NCT02613507 Bristol-Myers Squibb Non-Small Cell Lung Cancer December 2015 Phase 3
NCT00159471 University of Southern California|Sanofi Pancreatic Cancer February 2005
NCT01194960 Oxford BioMedica|MedSource Hormone Refractory Prostate Cancer August 2010 Phase 2
NCT01286766 Yonsei University Gastric Cancer September 2009 Phase 2
NCT00004235 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer January 2000 Phase 2
NCT01368848 Arbeitsgemeinschaft medikamentoese Tumortherapie|Sanofi|Roche Pharma AG NSCLC April 2010 Phase 2
NCT00966914 BioNumerik Pharmaceuticals, Inc. Non-small Cell Lung Cancer April 2010 Phase 3
NCT03061643 Samsung Medical Center Prostatic Neoplasm February 8, 2017 Phase 2
NCT01645748 Chonnam National University Hospital|Chungbuk National University|Chonbuk National University|Chungnam National University Head and Neck Cancer October 2008 Phase 2
NCT00453635 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer December 2003 Phase 2
NCT01385228 Daniel George, MD|GlaxoSmithKline|Duke University Prostate Cancer June 2011 Phase 1
NCT00070252 National Cancer Institute (NCI) Adult Solid Neoplasm|Inflammatory Breast Carcinoma|Male Breast Carcinoma|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer September 2003 Phase 1|Phase 2
NCT02633176 Sun Yat-sen University|Chinese Southwest Oncology Group Nasopharyngeal Carcinoma January 2015 Phase 3
NCT00273546 Sanofi Cancer May 1999 Phase 3
NCT00833859 H. Lee Moffitt Cancer Center and Research Institute|Sanofi Pancreatic Neoplasms March 2009 Phase 2
NCT02171741 Boehringer Ingelheim Neoplasms April 2005 Phase 1
NCT02604342 Hoffmann-La Roche Non-small Cell Lung Cancer November 3, 2015 Phase 3
NCT00604435 Xijing Hospital Breast Cancer February 2008 Phase 2
NCT02852798 Jiangsu ShengDiYa Medicine Co., Ltd.|Dongguan People's Hospital Nonsquamous Nonsmall Cell Neoplasm of Lung August 2016
NCT00075543 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Ovarian Cancer July 2003 Phase 1|Phase 2
NCT00562523 Bayer|Amgen Neoplasms November 2007 Phase 1
NCT00222144 University of Kansas|Novartis|Kansas Masonic Cancer Research Institute|University of Kansas Medical Center Lung Cancer September 2004 Phase 2
NCT00206453 Baylor Breast Care Center|United States Department of Defense Breast Cancer January 2002 Phase 2
NCT00532155 Sanofi|Regeneron Pharmaceuticals Carcinoma|Non Small Cell Lung September 2007 Phase 3
NCT02409199 Shanghai Zhongshan Hospital Gastric Carcinoma June 2015 Phase 2|Phase 3
NCT01526499 Fudan University Breast Cancer December 2011 Phase 2
NCT00557206 Minneapolis Veterans Affairs Medical Center|Sanofi Neoplasms|Head and Neck Neoplasms April 2005 Phase 2
NCT02623153 Tianshu Liu|Shanghai Zhongshan Hospital Gastric Cancer January 2016 Phase 2
NCT00086333 Seattle Genetics, Inc. Non-Small Cell Lung Carcinoma July 2004 Phase 2
NCT02799602 Bayer|Orion Corporation, Orion Pharma Prostatic Neoplasms November 30, 2016 Phase 3
NCT00254384 M.D. Anderson Cancer Center|Sanofi|Genentech, Inc. Lung Cancer October 2005
NCT03013504 Prestige Biopharma Pte Ltd HER2 Positive Breast Cancer June 2017 Phase 3
NCT00084435 Southwest Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer July 2005 Phase 2
NCT00446290 Asan Medical Center Stomach Cancer March 2006 Phase 1
NCT00601692 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Esophageal Cancer April 2003 Phase 1
NCT00536107 AstraZeneca Carcinoma, Non-Small-Cell Lung October 2007 Phase 4
NCT00069888 Sanofi Prostate Cancer November 2001 Phase 2
NCT00821912 Karolinska University Hospital Cancer of the Esophagus|Gastric Cardia Carcinoma March 2006 Phase 1|Phase 2
NCT02283320 BIND Therapeutics KRAS Positive Patients With Non-small Cell Lung Cancer|Squamous Cell Non-small Cell Lung Cancer September 2014 Phase 2
NCT00232479 University of Miami|Aventis Pharmaceuticals Breast Cancer September 2005 Phase 2
NCT00183742 University of Southern California|Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA Cancer|Carcinoma December 2000 Phase 1
NCT00146042 University of Michigan Cancer Center|Genentech, Inc. HER-2 Positive Metastatic Breast Cancer March 1999 Phase 2
NCT00442026 Hellenic Oncology Research Group|University Hospital of Crete Non-small-cell Lung Cancer December 2006 Phase 3
NCT00865982 Charite University, Berlin, Germany|Roche Pharma AG|Sanofi Gastric Cancer|Esophageal Cancer September 2008 Phase 2
NCT00201825 Tony Bekaii-Saab|Roche Pharma AG|Ohio State University Comprehensive Cancer Center Lung Cancer|Non-Small-Cell Lung Carcinoma December 2004 Phase 2
NCT00545246 Sanofi|Regeneron Pharmaceuticals Neoplasms October 2007 Phase 1
NCT00356122 Sanofi|Genentech, Inc. Non-Small Cell Lung Cancer July 2006 Phase 2
NCT00107510 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer August 2005 Phase 2
NCT01208480 Severance Hospital Breast Cancer September 2010 Phase 2
NCT00772681 Sanofi Head and Neck Neoplasms October 2004 Phase 4
NCT00291577 Pfizer Breast Neoplasms July 2006 Phase 1
NCT00118053 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Aventis Pharmaceuticals|Rutgers, The State University of New Jersey Breast Cancer April 2005 Phase 2
NCT00151047 University of Michigan Cancer Center Prostate Cancer March 2003 Phase 2
NCT00872989 Southwest Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer March 2010 Phase 2
NCT00807261 Asan Medical Center|Severance Hospital|Korea University Anam Hospital|Samsung Medical Center Sarcoma September 2008 Phase 2
NCT00002825 National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Neuroblastoma|Sarcoma January 1997 Phase 2
NCT00206466 Baylor Breast Care Center|Baylor College of Medicine Breast Cancer April 2002 Phase 2
NCT02488564 Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori HER-2 Positive Breast Cancer October 2014 Phase 2
NCT00318903 University of Alabama at Birmingham|Aventis Pharmaceuticals|Pharmacia and Upjohn Esophageal Cancer|Cancer of the Esophagus|Esophagus Cancer|Esophageal Neoplasm|Cancer of Esophagus January 2002 Phase 2
NCT00429871 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer May 2002 Phase 3
NCT02896855 Hoffmann-La Roche Breast Cancer September 13, 2016 Phase 3
NCT00209092 Emory University|Georgia Center for Oncology Research & Education|Sanofi Breast Cancer August 2006 Phase 2
NCT00567190 Genentech, Inc.|Hoffmann-La Roche Metastatic Breast Cancer February 12, 2008 Phase 3
NCT00703326 Eli Lilly and Company Breast Cancer August 2008 Phase 3
NCT02590055 Samsung Medical Center Carcinoma of Unknown Primary October 2015 Phase 2
NCT00139711 Pfizer Carcinoma, Non-Small-Cell Lung March 2003 Phase 2
NCT00743379 Threshold Pharmaceuticals Non-Small Cell Lung Cancer|Prostate Cancer|Pancreatic Cancer August 2008 Phase 1|Phase 2
NCT00591149 University of Kansas Medical Center|Sanofi Head and Neck Cancer|Carcinoma, Squamous June 2007 Phase 2
NCT00393939 Pfizer Breast Neoplasms February 2007 Phase 3
NCT00038194 M.D. Anderson Cancer Center|Novartis Prostate Cancer October 2001 Phase 1
NCT02953340 Spectrum Pharmaceuticals, Inc Neutropenia|Breastcancer February 2017 Phase 3
NCT00493766 Novartis Pharmaceuticals|Novartis Hormone Refractory Prostate Cancer May 2006 Phase 1
NCT01362296 GlaxoSmithKline Lung Cancer, Non-Small Cell September 2011 Phase 2
NCT00129376 Spanish Breast Cancer Research Group|Sanofi Breast Cancer December 2002 Phase 2
NCT00041171 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Adult Solid Tumor|Breast Cancer|Head and Neck Cancer|Kidney and Urinary Cancer|Male Reproductive Cancer|Thorax and Respiratory Cancer Phase 3
NCT00733616 Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Sanofi|Hoffmann-La Roche Gastric Cancer November 2008 Phase 2
NCT00258362 Masonic Cancer Center, University of Minnesota|Sanofi Endometrial Cancer July 2005 Phase 2
NCT00121095 Cytogen Corporation Prostatic Neoplasms July 2005 Phase 1|Phase 2
NCT00448097 The Methodist Hospital System|Bristol-Myers Squibb|ImClone LLC Prostatic Neoplasms February 2007 Phase 2
NCT00151073 University of Michigan Cancer Center|Aventis Pharmaceuticals|Novartis Hormone-Refractory Prostate Cancer April 2002 Phase 2
NCT02144012 Hoffmann-La Roche Metastatic Breast Cancer June 2014 Phase 3
NCT02437370 University of California, Davis|Merck Sharp & Dohme Corp. Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter|Recurrent Bladder Carcinoma|Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter|Regional Urothelial Carcinoma of the Renal Pelvis and Ureter|Stage III Bladder Urothelial Carcinoma|Stage III Urethral Cancer|Stage IV Bladder Urothelial Carcinoma|Stage IV Urethral Cancer|Urethral Urothelial Carcinoma August 2015 Phase 1
NCT00683787 Roswell Park Cancer Institute Gastric Cancer May 2008 Phase 2
NCT02447380 Samsung Medical Center Advanced Gastric Adenocarcinoma March 2017 Phase 2
NCT00206505 Baylor Breast Care Center|Aventis Pharmaceuticals Breast Cancer January 1999 Phase 2
NCT00887315 University of Chicago Non-small Cell Lung Cancer April 2009 Phase 2
NCT01301040 Jules Bordet Institute|Sanofi Breast Cancer March 2011 Phase 2
NCT00952003 Arbeitsgemeinschaft medikamentoese Tumortherapie|Pfizer|Sanofi|Roche Pharma AG Gastric Cancer|Unresectable July 2009 Phase 2
NCT00062439 Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|American College of Surgeons|North Central Cancer Treatment Group|NCIC Clinical Trials Group|Cancer and Leukemia Group B Lung Cancer July 2003 Phase 2
NCT00296816 Sanofi Ovarian Cancer March 2006 Phase 2
NCT00664105 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Lung Cancer February 2004 Phase 2
NCT00386555 Arog Pharmaceuticals, Inc. Carcinoma, Non-Small-Cell Lung May 2007 Phase 2
NCT00377780 Laurence J.C. van Warmerdam|Cephalon|Sanofi|Catharina Ziekenhuis Eindhoven Breast Cancer|Neoplasm Metastasis August 2006 Phase 2
NCT00480857 University of Michigan Cancer Center|Sanofi Prostate Cancer March 2007 Phase 2
NCT01593748 Medical University of South Carolina|Novartis Sarcoma May 2012 Phase 2
NCT00459043 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital|Loyola University|AstraZeneca Squamous Cell Carcinoma of Head and Neck March 2007 Phase 2
NCT01038752 Optimum Therapeutics, LLC Non-small Cell Lung Cancer August 2010 Phase 2
NCT00049283 National Cancer Institute (NCI) Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squ September 2002 Phase 1
NCT02610556 Sun Yat-sen University|Affiliated Tumor Hospital of Guangzhou Medical University|The First Affiliated Hospital of Guangzhou Medical University|The First Affiliated Hospital of Guangdong Pharmaceutical University Nasopharyngeal Carcinoma January 2016 Phase 2
NCT00193453 SCRI Development Innovations, LLC|Bristol-Myers Squibb Lung Cancer July 2005 Phase 2
NCT02640898 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Gastric Cancer December 2015
NCT03002064 Sun Yat-sen University Esophagus Cancer|Chemotherapy Effects December 2016 Phase 3
NCT01041235 Azaya Therapeutics, Inc. Solid Tumor|Breast Cancer|Ovarian Cancer|Pancreatic Cancer|Non-Small Cell Lung December 2009 Phase 1
NCT00663832 Novartis Pharmaceuticals|Novartis Prostate Cancer February 2008 Phase 1
NCT00309556 Austrian Breast & Colorectal Cancer Study Group|Amgen|Ebewe Pharma GmbH|Hoffmann-La Roche|Sanofi Breast Cancer February 2005 Phase 3
NCT00559429 Sidney Kimmel Comprehensive Cancer Center|Sanofi|Cytogen Corporation Prostate Cancer December 2004 Phase 1
NCT00820872 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer February 2009 Phase 2
NCT00005908 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer|Breast Neoplasm June 2000 Phase 2
NCT00674167 National University Hospital, Singapore Gastric Cancer May 2007 Phase 2
NCT01630733 OncoGenex Technologies Non-Small Cell Lung Cancer September 2012 Phase 3
NCT00527449 Klinikum Weissenfels Primary Breast Cancer May 2006 Phase 2
NCT00942578 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Metastatic Prostate Cancer July 16, 2009 Phase 2
NCT03150875 Innovent Biologics (Suzhou) Co. Ltd. Non-squamous Cell NSCLC June 2017 Phase 3
NCT00415779 National Cancer Institute, Naples Metastatic Prostate Cancer July 2006 Phase 1
NCT00996502 Columbia University|Genentech, Inc. Prostate Cancer July 2006 Phase 1|Phase 2
NCT02947061 Chinese Academy of Medical Sciences Breast Cancer Recurrent April 2015 Phase 2
NCT00095199 Eli Lilly and Company|ImClone LLC Non Small Cell Lung Cancer January 2005 Phase 3
NCT00424853 Sanofi Carcinoma, Non-Small-Cell Lung May 2005 Phase 2
NCT00290966 Sanofi Stomach Neoplasm October 1998 Phase 2|Phase 3
NCT00136526 University of Washington|Sanofi Prostate Cancer December 2002 Phase 2
NCT02008227 Hoffmann-La Roche Non-Squamous Non-Small Cell Lung Cancer March 2014 Phase 3
NCT01251653 Boehringer Ingelheim Neoplasms November 2010
NCT00917748 Sanofi Prostatic Neoplasms|Breast Cancer June 2009 Phase 3
NCT00084734 Roswell Park Cancer Institute|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific May 2002 Phase 1
NCT00085332 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Cancer July 2004 Phase 2
NCT00256360 Universitaire Ziekenhuizen Leuven|St-Augustinus Wilrijk Breast Cancer September 2005 Phase 2
NCT00174772 Sanofi Lung Neoplasms March 2004 Phase 2
NCT01794845 University of Miami Squamous Cell Carcinoma|Head and Neck Cancer|Recurrent Disease June 3, 2013 Phase 2
NCT00258739 Sanofi Lung Neoplasms October 2001 Phase 2
NCT00255606 University of Tampere|National Cancer Institute (NCI) Prostate Cancer August 2005 Phase 3
NCT02288247 Astellas Pharma Europe Ltd.|Medivation, Inc.|Astellas Pharma Inc Metastatic Castration Resistant Prostate Cancer December 1, 2014 Phase 3
NCT01471470 Asan Medical Center|Roche Pharma AG Advanced Gastric Cancer July 2010 Phase 2
NCT00723086 Sanofi Therapy, Prostatic Neoplasms May 2005 Phase 2
NCT00833326 Array BioPharma Advanced Cancer January 2009 Phase 1
NCT00322400 Amgen Locally Recurrent and Metastatic Breast Cancer March 2006 Phase 1
NCT00058448 Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Penile Cancer October 2004 Phase 2
NCT02668393 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung March 7, 2016 Phase 1
NCT00321698 OHSU Knight Cancer Institute Prostate Cancer January 2006 Phase 1|Phase 2
NCT01608464 King Faisal Specialist Hospital & Research Center Carcinoma of Esophagus May 2012 Phase 2
NCT00343512 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer February 2004 Phase 2
NCT00005096 Dana-Farber Cancer Institute|National Cancer Institute (NCI) Prostate Cancer December 1999 Phase 2
NCT00174707 Sanofi Breast Neoplasms December 1997 Phase 3
NCT01282463 Eli Lilly and Company Carcinoma of Urinary Tract|Urethral Carcinoma|Carcinoma of Ureter|Carcinoma of Renal Pelvis April 2011 Phase 2
NCT00430183 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|NCIC Clinical Trials Group|Southwest Oncology Group Prostate Cancer December 2006 Phase 3
NCT01145508 National Cancer Institute (NCI) Hormone-Resistant Prostate Cancer|Prostate Adenocarcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer August 2010 Phase 2
NCT02061631 Sanofi Squamous Cell Carcinoma of Head and Neck May 2014 Phase 2
NCT00478049 AstraZeneca NSCLC September 2005 Phase 3
NCT01253642 OHSU Knight Cancer Institute|National Cancer Institute (NCI)|The Wayne D. Kuni and Joan E. Kuni Foundation Hormone-Resistant Prostate Cancer|Metastatic Prostatic Adenocarcinoma|Prostate Adenocarcinoma|Recurrent Prostate Carcinoma July 12, 2010 Phase 2
NCT00003445 Grupo Oncologico Cooperativo del Sur|National Cancer Institute (NCI) Cervical Cancer December 1997 Phase 2
NCT00132379 Active Biotech AB Carcinoma, Non-Small-Cell Lung November 2005 Phase 1
NCT00995293 Sanofi Head and Neck Neoplasms August 2009 Phase 3
NCT01624025 Yonsei University Metastatic Advanced Gastric Cancer June 2012 Phase 2
NCT00002903 European Organisation for Research and Treatment of Cancer - EORTC Extragonadal Germ Cell Tumor|Ovarian Cancer|Testicular Germ Cell Tumor July 1995 Phase 2
NCT00281840 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer September 2005 Phase 2
NCT01004601 Chang Gung Memorial Hospital Non Small Cell Lung Cancer March 2005
NCT00263016 Sanofi Carcinoma, Non-Small-Cell Lung May 2005 Phase 2
NCT00063934 National Cancer Institute (NCI) Male Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer May 2003 Phase 1|Phase 2
NCT00041067 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer September 2002 Phase 2
NCT00253344 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific June 2005 Phase 1
NCT00543387 Merck Sharp & Dohme Corp. Cancer, Neoplasms, Tumors March 2008 Phase 1
NCT01126138 Chinese Academy of Medical Sciences|Hoffmann-La Roche Carcinoma, Invasive Ductal, Breast July 2010 Phase 3
NCT01576029 Sanofi Prostatic Neoplasms August 2012 Phase 2
NCT00142038 Charite University, Berlin, Germany Stomach Neoplasm|Neoplasm Metastasis March 2004 Phase 2
NCT00066443 NCIC Clinical Trials Group|Canadian Cancer Trials Group Breast Cancer February 2003 Phase 1|Phase 2
NCT00099086 David T. Marshall|Medical University of South Carolina Prostate Cancer July 2010 Phase 1
NCT00004037 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer June 1998 Phase 2
NCT00216125 Nasser Hanna, M.D.|Sanofi|Walther Cancer Institute|Hoosier Cancer Research Network Non-Small Cell Lung Cancer February 2002 Phase 3
NCT00373204 Pharmacyclics LLC. Lung Cancer May 2006 Phase 2
NCT00264134 Kentuckiana Cancer Institute Non-small Cell Lung Cancer|Extensive Stage Unresectable June 2003 Phase 1|Phase 2
NCT00345059 National Cancer Institute, Naples Advanced Non-Small Cell Lung Cancer May 2005 Phase 3
NCT01191216 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 2010 Phase 1
NCT01266512 Sanofi Lung Neoplasms January 2011 Phase 2
NCT00503984 University of Miami Prostate Cancer|Pain May 2007 Phase 1|Phase 2
NCT00658697 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Beth Israel Deaconess Medical Center|Genentech, Inc. Prostate Cancer June 2008 Phase 2
NCT00118183 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Large Cell Lung Cancer|Malignant Pleural Effusion|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer July 2005 Phase 2
NCT00004081 Beth Israel Deaconess Medical Center|Dana-Farber Cancer Institute Ovarian Cancer|Peritoneal Cavity Cancer July 1999 Phase 2
NCT00177242 University of Pittsburgh|AstraZeneca Cancer September 2004 Phase 2
NCT01771289 Peking University People's Hospital Non-small Cell Lung Cancer January 2013 Phase 2
NCT02964455 Sun Yat-sen University Esophageal Squamous Cell Carcinoma November 2016 Phase 1
NCT00258388 NCIC Clinical Trials Group|Canadian Cancer Trials Group Prostate Cancer June 2005 Phase 2
NCT00319514 Gachon University Gil Medical Center Advanced Non-Small Cell Lung Cancer April 2004 Phase 2
NCT01064479 M.D. Anderson Cancer Center|OSI Pharmaceuticals|Sanofi Head and Neck Cancer|Squamous Cell Carcinoma of the Head and Neck February 2010 Phase 2
NCT00424606 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer June 2001 Phase 3
NCT00133224 Cell Genesys Prostate Cancer July 2005 Phase 3
NCT00669773 National University Hospital, Singapore Breast Cancer February 2007 Phase 2
NCT00089609 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Prostatic Neoplasms August 2004 Phase 2
NCT00303888 Yale University|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer May 2006 Phase 1
NCT01614002 Onkovis GmbH|AKP Freiburg GmbH Carcinoma May 2012
NCT00364195 YM BioSciences Metastatic Breast Cancer June 2006 Phase 2
NCT00315211 Aultman Hospital|GlaxoSmithKline Mediastinal Neoplasms November 2004 Phase 2
NCT01958580 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Stage IA Uterine Sarcoma|Stage IB Uterine Sarcoma|Stage IC Uterine Sarcoma|Stage IIA Uterine Sarcoma|Stage IIB Uterine Sarcoma|Stage IIIA Uterine Sarcoma|Stage IIIB Uterine Sarcoma|Stage IIIC Uterine Sarcoma|Stage IVA Uterine Sarcoma|Stage IVB Uterine Sarcoma|Uterine Corpus Leiomyosarcoma June 2013
NCT03147378 Modra Pharmaceuticals|The Netherlands Cancer Institute Solid Tumor, Adult May 10, 2017 Phase 1
NCT00490646 R-Pharm Metastatic Breast Cancer February 2008 Phase 2
NCT00399087 AEterna Zentaris Neoplasms November 2004 Phase 1
NCT01951157 PharmaMar Non-Small Cell Lung Cancer (NSCLC) October 2013 Phase 2
NCT01718626 Hebei Tumor Hospital Gastric Cancer October 2012 Phase 2
NCT00270582 Far Eastern Memorial Hospital Carcinoma, Non-Small-Cell Lung November 2005 Phase 2
NCT00970684 Nathan Pennell, MD, PhD|National Cancer Institute (NCI)|Case Comprehensive Cancer Center Lung Cancer September 2009 Phase 2
NCT00431613 Hellenic Oncology Research Group|University Hospital of Crete Non Small Cell Lung Cancer March 2006 Phase 2
NCT02231164 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung October 2014 Phase 3
NCT00525408 Cadila Pharnmaceuticals Hormone Refractory Prostate Cancer November 2007 Phase 2
NCT00288054 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer April 2006 Phase 1
NCT00519285 Sanofi|Regeneron Pharmaceuticals Prostatic Neoplasms|Neoplasm Metastasis August 2007 Phase 3
NCT02216617 Groupe Oncologie Radiotherapie Tete et Cou HNSCC August 2014 Phase 1
NCT02913196 Weill Medical College of Cornell University|Janssen Scientific Affairs, LLC Prostate Cancer Metastatic December 2016 Phase 1
NCT00086957 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer January 2004 Phase 1|Phase 2
NCT00660699 Washington University School of Medicine Cholangiocarcinoma Cancer|Gallbladder Cancer|Pancreatic Cancer|Ampullary Cancer September 2002 Phase 2
NCT00268671 Sanofi Head and Neck Neoplasms August 2003 Phase 1|Phase 2
NCT00215345 Department of Veterans Affairs, New Jersey|Pfizer|Sanofi Prostate Cancer August 2002 Phase 2
NCT00217815 NeuTec Pharma Cancer of the Breast September 2005 Phase 1|Phase 2
NCT00226239 University of Pittsburgh|Bristol-Myers Squibb Cancer October 2005 Phase 2
NCT00757172 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Amgen Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer January 2009 Phase 2
NCT00473954 EGEN, Inc. Ovarian Neoplasms April 2007 Phase 1
NCT02401542 BioClin Therapeutics, Inc. Locally Advanced or Metastatic Urothelial Cell Carcinoma|Urinary Bladder Disease|Urological Diseases June 2015 Phase 1|Phase 2
NCT00173888 National Taiwan University Hospital Non-small Cell Lung Cancer July 2003 Phase 2
NCT01110486 AbbVie (prior sponsor, Abbott)|AbbVie Advanced Solid Tumors March 2010 Phase 1
NCT01308567 Sanofi Prostate Cancer May 2011 Phase 3
NCT00528866 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Prostate Cancer April 2008 Phase 2
NCT00527124 National Cancer Institute (NCI) Adenocarcinoma of the Prostate|Stage IV Prostate Cancer November 2007 Phase 2
NCT00847444 Philip Hepp|Ludwig-Maximilians - University of Munich Breast Cancer February 2009 Phase 3
NCT00005800 H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|Aventis Pharmaceuticals Breast Cancer April 1999 Phase 2
NCT00002662 Aventis Pharmaceuticals|National Cancer Institute (NCI) Breast Cancer August 1994 Phase 3
NCT01313390 University College, London Head and Neck Cancer June 2009 Phase 1|Phase 2
NCT00456989 James Graham Brown Cancer Center Prostate Cancer January 2004 Phase 1|Phase 2
NCT00260611 University of Pittsburgh|Sanofi Prostate Cancer November 2004 Phase 2
NCT01382706 University of Southern California|National Cancer Institute (NCI)|GlaxoSmithKline Recurrent Bladder Cancer|Stage III Bladder Cancer|Stage IV Bladder Cancer|Transitional Cell Carcinoma of the Bladder June 13, 2011 Phase 2
NCT01497041 Korean South West Oncology Group Carcinoma, Non-Small-Cell Lung|Carcinoma, Squamous|Carcinoma, Large Cell February 2011 Phase 2
NCT00934856 Hoffmann-La Roche Breast Cancer July 2009 Phase 1|Phase 2
NCT00148902 GlaxoSmithKline Solid Tumor Cancer April 2003 Phase 1
NCT01151384 INSYS Therapeutics Inc Solid Tumors February 2008 Phase 1
NCT01851746 Wuhan University Recurrent Ovarian Cancer March 2013
NCT00030641 Genta Incorporated|National Cancer Institute (NCI) Lung Cancer October 2001 Phase 2|Phase 3
NCT00077857 Hoffmann-La Roche Breast Cancer July 2003 Phase 2
NCT02124902 Washington University School of Medicine Triple Negative Breast Neoplasms July 7, 2014 Phase 2
NCT00079170 National Cancer Institute (NCI) Breast Cancer January 2004
NCT00446030 Sanofi Breast Neoplasms March 2007 Phase 2
NCT00191139 Eli Lilly and Company Non-small Cell Lung Cancer March 2003 Phase 2
NCT02484677 Assistance Publique Hopitaux De Marseille Patients With Head and Neck Cancer (ORL) June 2015 Phase 4
NCT01129206 Ohio State University Comprehensive Cancer Center|National Comprehensive Cancer Network|Spectrum Pharmaceuticals, Inc Adenocarcinoma of the Esophagus|Adenocarcinomas of the Gastroesophageal Junction|Recurrent Esophageal Cancer|Squamous Cell Carcinoma of the Esophagus|Stage IV Esophageal Cancer July 2010 Phase 2
NCT00169182 Groupe Oncologie Radiotherapie Tete et Cou|Sanofi Larynx Cancer|Hypopharynx Cancer December 2000 Phase 3
NCT00193128 SCRI Development Innovations, LLC|Sanofi-Synthelabo|Aventis Pharmaceuticals Esophagus Cancer April 2004 Phase 1|Phase 2
NCT00104624 UNICANCER Breast Cancer May 2005 Phase 2
NCT00097851 Medigen Biotechnology Corporation Carcinoma, Non-Small-Cell Lung February 2004 Phase 2
NCT00852332 Centre Jean Perrin Breast Cancer August 2009 Phase 2
NCT00771953 University of Maryland|Tragara Pharmaceuticals, Inc. Lung Cancer|Non Small Cell Lung Cancer November 2008 Phase 2
NCT00721747 Grupo Oncológico Gallego|Pivotal S.L. Breast Cancer January 2008 Phase 2
NCT00527761 M.D. Anderson Cancer Center|Aventis Pharmaceuticals Metastatic Melanoma August 2004 Phase 1
NCT00268710 Sanofi|Canadian Urologic Oncology Group Prostatic Neoplasms February 2004 Phase 2
NCT00243113 Aichi Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer June 2004 Phase 2
NCT01155791 Sandy Srinivas|Stanford University Urologic Neoplasms|Prostate Cancer|Prostate Cancer Metastatic Disease April 2010 Phase 1
NCT00813332 Simcere Pharmaceutical Co., Ltd Advanced NSCLC|Recurrent NSCLC October 2008 Phase 4
NCT00225056 Oncology Specialties, Alabama Metastatic Breast Cancer October 2003 Phase 2
NCT00957125 Thomas Hatschek|Karolinska University Hospital Breast Cancer September 2008 Phase 2
NCT00826852 Sanofi Lung Neoplasms October 2003 Phase 2
NCT00372736 NCIC Clinical Trials Group|Canadian Cancer Trials Group Unspecified Adult Solid Tumor, Protocol Specific June 2006 Phase 1
NCT00258375 NCIC Clinical Trials Group|Canadian Cancer Trials Group Breast Cancer June 2005 Phase 2
NCT00022022 Istituto Nazionale per lo Studio e la Cura dei Tumori|National Cancer Institute (NCI) Lung Cancer December 2000 Phase 3
NCT00114205 University of Virginia|National Cancer Institute (NCI) Metastatic Cancer July 2003 Phase 1
NCT00047801 Telik Carcinoma, Non-small-cell Lung October 2002 Phase 1|Phase 2
NCT00283062 Sanofi Prostatic Neoplasms December 2005 Phase 3
NCT01671319 University of Wisconsin, Madison|Amgen Female Breast Cancer June 2011 Phase 2
NCT00227708 UNICANCER|National Cancer Institute (NCI) Lung Cancer June 2005 Phase 2
NCT01927744 M.D. Anderson Cancer Center|Astellas Pharma Inc|OSI Pharmaceuticals|Kadoorie Foundation Head and Neck Cancer December 2013 Phase 2
NCT00816543 Sanofi Gastric Cancer December 2008 Phase 2
NCT00949247 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer December 2009 Early Phase 1
NCT01985724 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer October 2007 Phase 3
NCT00114192 University of Virginia|National Cancer Institute (NCI) Lung Cancer June 2004 Phase 2
NCT02923258 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University|Fudan University Head and Neck Squamous Cell Carcinoma November 2016 Phase 2|Phase 3
NCT00657423 Xijing Hospital|Yantai Medgenn Ltd. Lung Neoplasms April 2008 Phase 3
NCT00257348 University of California, Irvine|Aventis Pharmaceuticals Cervical Cancer March 2004 Phase 2
NCT01108042 Orlando Guntinas-Lichius, Prof. Dr. med.|University of Jena Oropharynx Cancer|Squamous Cell Carcinoma of the Oral Cavity November 2009 Phase 1|Phase 2
NCT00231855 Montefiore Medical Center|Sanofi|GlaxoSmithKline Ovarian Neoplasms|Uterine Neoplasms November 2004 Phase 2
NCT00080080 Point Therapeutics Lung Cancer Phase 2
NCT00471159 Pfizer Breast Neoplasms August 2007 Phase 2
NCT00084786 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 2004 Phase 1
NCT00937417 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer|Head and Neck Cancer|Lung Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific September 2008 Phase 1
NCT00925418 Institut Paoli-Calmettes Breast Neoplasms|Prostate Cancer|Nail Diseases September 2006 Phase 3
NCT00327340 OncoGenex Technologies Prostate Cancer July 2006 Phase 2
NCT01796028 Centre Antoine Lacassagne Prostatic Neoplasms January 2013 Phase 2
NCT00620100 Sanofi Breast Neoplasms September 2004 Phase 2
NCT00002901 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer|Head and Neck Cancer|Lung Cancer|Ovarian Cancer|Unspecified Adult Solid Tumor, Protocol Specific December 1996 Phase 1
NCT00660816 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer January 2008 Phase 2
NCT00193271 SCRI Development Innovations, LLC|Aventis Pharmaceuticals Prostate Cancer August 2004 Phase 2
NCT01862328 Millennium Pharmaceuticals, Inc.|Takeda Solid Tumors July 1, 2013 Phase 1
NCT00032825 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Prostatic Neoplasms March 19, 2002 Phase 1
NCT00441740 Hellenic Oncology Research Group|University Hospital of Crete Non Small Cell Lung Cancer April 2004 Phase 3
NCT01298193 Spanish Breast Cancer Research Group|Merck Sharp & Dohme Corp. Breast Cancer May 2011 Phase 4
NCT00321633 University College London Hospitals|National Cancer Institute (NCI) brca1 Mutation Carrier|brca2 Mutation Carrier|Breast Cancer|Hereditary Breast/Ovarian Cancer (brca1, brca2) September 2005 Phase 2
NCT00193011 SCRI Development Innovations, LLC|Aventis Pharmaceuticals Breast Cancer March 2002 Phase 3
NCT00772863 Sanofi Ovarian Neoplasms September 2003 Phase 2
NCT02044354 Gustave Roussy, Cancer Campus, Grand Paris|Sanofi Metastatic Castration-resistant Prostate Cancer January 2014 Phase 3
NCT01810913 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IVA Squamous Cell Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVA Squamous Cell Carcinom March 2013 Phase 2|Phase 3
NCT00359671 Merck Sharp & Dohme Corp. Advanced Solid Tumors December 2006 Phase 1
NCT01312324 Samsung Medical Center Locally Advanced Stage III or IV Thymic Cancer February 2007 Phase 2
NCT00551759 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Esophageal Cancer June 2008 Phase 2
NCT02387216 Merrimack Pharmaceuticals Non-Small Cell Lung Cancer|NSCLC|Adenocarcinoma|Squamous Cell Carcinoma|Heregulin|Large Cell Carcinoma February 2015 Phase 2
NCT00085228 European Organisation for Research and Treatment of Cancer - EORTC Prostate Cancer April 2004 Phase 2
NCT00075465 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Gastric Cancer April 2001 Phase 2
NCT00589420 University of Pennsylvania|National Cancer Institute (NCI) Prostate Cancer October 2006 Phase 2
NCT02447406 Samsung Medical Center Advanced Gastric Adenocarcinoma April 30, 2015 Phase 1|Phase 2
NCT00916097 Sanofi Head and Neck Neoplasms July 2002 Phase 2
NCT00238199 OHSU Knight Cancer Institute|Sanofi Pancreatic Cancer June 2002 Phase 2
NCT00405210 Cliniques universitaires Saint-Luc- Université Catholique de Louvain Primary Disease|Prostate Cancer September 2006 Phase 1
NCT00127088 Gustave Roussy, Cancer Campus, Grand Paris Prostate Cancer October 2004 Phase 2
NCT00538525 King Faisal Specialist Hospital & Research Center Breast Cancer September 2007
NCT01270880 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer January 2011 Phase 2
NCT01917279 Binghe Xu|Hoffmann-La Roche|Chinese Academy of Medical Sciences Breast Neoplasms|Neoplasms by Site|Neoplasm Metastasis|Breast Diseases|Skin Diseases October 2013 Phase 3
NCT00357149 Sanofi Head and Neck Neoplasms January 2003 Phase 2
NCT00401180 The Cleveland Clinic|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific June 2002 Phase 1
NCT00075517 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Lung Cancer September 2003 Phase 2
NCT01367028 Austrian Breast & Colorectal Cancer Study Group|Hoffmann-La Roche|Cephalon Breast Cancer June 2011 Phase 2
NCT00191243 Eli Lilly and Company Breast Cancer March 2002 Phase 2
NCT00425750 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer August 2005 Phase 2
NCT00546364 R-Pharm Breast Neoplasms February 2008 Phase 2
NCT01243775 Chonnam National University Hospital|Chong Kun Dang Pharmaceutical Non-Small Cell Lung Cancer November 2010 Phase 2
NCT00273338 Novacea Prostate Cancer January 2006 Phase 3
NCT00642018 Eli Lilly and Company Prostate Cancer March 2008 Phase 2
NCT00193245 SCRI Development Innovations, LLC|AstraZeneca|Aventis Pharmaceuticals|GlaxoSmithKline Lung Cancer November 2000 Phase 2
NCT00004139 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer September 1999 Phase 2
NCT01173913 The Netherlands Cancer Institute Cancer September 2010 Phase 1
NCT00717951 Academy Military Medical Science, China|Chinese Academy of Medical Sciences Advanced Breast Cancer May 2008 Phase 2
NCT00953420 Baylor College of Medicine|Texas Children's Hospital|The Methodist Hospital System|Center for Cell and Gene Therapy, Baylor College of Medicine|M.D. Anderson Cancer Center Nasopharyngeal Carcinoma November 2009 Phase 2
NCT00520845 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Lung Cancer October 2007 Phase 2
NCT02182622 Martin Gutierrez|Novartis|Hackensack University Medical Center Prostate Cancer July 2014 Phase 1
NCT00190489 Japan Clinical Oncology Group|Ministry of Health, Labour and Welfare, Japan Breast Cancer|Neoplasm Metastasis January 1999 Phase 3
NCT00066677 Fox Chase Cancer Center Pancreatic Cancer October 2003 Phase 2
NCT00015938 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer May 2001 Phase 2
NCT00156312 University of Michigan Cancer Center Breast Cancer July 2003
NCT00099190 ArQule Carcinoma December 2004 Phase 1
NCT00313781 Pfizer Prostatic Neoplasms May 2006 Phase 2
NCT00488982 University of California, San Francisco|Genzyme, a Sanofi Company Prostate Cancer April 2007 Phase 2
NCT00813072 PharmaEngine Stomach Neoplasms|Esophageal Neoplasms November 2007 Phase 2
NCT00251407 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital Solid Tumor September 1999 Phase 1
NCT00193323 SCRI Development Innovations, LLC|Aventis Pharmaceuticals Lung Cancer August 2001 Phase 2
NCT00293332 University of California, San Francisco|National Cancer Institute (NCI) Lung Cancer December 2005 Phase 2
NCT00003066 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer February 1997 Phase 2
NCT00026078 Grupo Oncologico Cooperativo del Sur|National Cancer Institute (NCI) Breast Cancer March 2001 Phase 2
NCT00148291 West Japan Thoracic Oncology Group Lung Cancer June 1999 Phase 3
NCT01107756 Sanofi Neoplasms (no Otherwise Specified) March 2010 Phase 4
NCT00002775 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Prostate Cancer February 1998 Phase 1|Phase 2
NCT00004243 City of Hope Medical Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 2000 Phase 1
NCT00114816 Finnish Breast Cancer Group|Hoffmann-La Roche|Sanofi|AstraZeneca Breast Cancer January 2004 Phase 3
NCT00004223 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer December 1999 Phase 2
NCT00066768 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer July 2003 Phase 1
NCT03070886 NRG Oncology|National Cancer Institute (NCI) Stage I Prostate Adenocarcinoma|Stage II Prostate Adenocarcinoma|Stage III Prostate Adenocarcinoma January 16, 2017 Phase 2|Phase 3
NCT02748213 Hoffmann-La Roche Breast Cancer February 2002 Phase 2
NCT00761241 Benaroya Research Institute|Sanofi Pancreatic Cancer September 2008 Phase 2
NCT02494921 Rahul Aggarwal|University of California, San Francisco Prostate Cancer September 2015 Phase 1|Phase 2
NCT02268695 Groupe Oncologie Radiotherapie Tete et Cou|Grupo Español de Tratamiento de Tumores de Cabeza y Cuello|AIO-Studien-gGmbH Head and Neck Squamous Cell Carcinoma October 2014 Phase 2
NCT00193232 SCRI Development Innovations, LLC|Aventis Pharmaceuticals|Millennium Pharmaceuticals, Inc. Prostate Cancer May 2004 Phase 2
NCT00003864 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Esophageal Cancer July 1999 Phase 2
NCT00193570 SCRI Development Innovations, LLC|GlaxoSmithKline|Genentech, Inc. Cancer February 2002 Phase 1
NCT01012141 Centre Jean Perrin Metastatic Prostate Cancer September 2009 Phase 2
NCT00020046 National Institutes of Health Clinical Center (CC) Stage IV Prostate Cancer|Adenocarcinoma of the Prostate|Recurrent Prostate Cancer December 1999 Phase 2
NCT01038661 Sanofi Lung Neoplasms November 2009 Phase 3
NCT00415285 Georgia Center for Oncology Research & Education|Sanofi Breast Neoplasms December 2006 Phase 2
NCT00054184 CTI BioPharma Lung Cancer January 2003 Phase 3
NCT00016185 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 2001 Phase 1
NCT00039520 Fox Chase Cancer Center|National Cancer Institute (NCI) Breast Cancer January 2002 Phase 2
NCT00801411 National Cancer Centre, Singapore|National Cancer Institute (NCI) Breast Cancer October 2008 Phase 2
NCT00178269 University of Rochester Cervix Neoplasm January 2005 Phase 2
NCT00215748 Geriatric Oncology Consortium|Sanofi Breast Cancer|Lung Cancer August 2004 Phase 2
NCT00212082 National University Hospital, Singapore Metastatic Breast Cancer April 2002 Phase 2
NCT00050596 Bristol-Myers Squibb Prostate Cancer November 2002 Phase 2
NCT00004886 European Organisation for Research and Treatment of Cancer - EORTC Unspecified Adult Solid Tumor, Protocol Specific December 1999 Phase 1
NCT00404066 George Albert Fisher|GlaxoSmithKline|Sanofi|Stanford University Breast Cancer|Metastatic Breast Cancer October 2006 Phase 2
NCT00004923 Yale University|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific April 1999 Phase 1|Phase 2
NCT01396655 Seoul National University Hospital Breast Cancer July 2006 Phase 2
NCT02889666 Shanghai Jiao Tong University School of Medicine|Shanghai 10th People's Hospital|Jilin University|Jiangxi Provincial Cancer Hospital|Shanghai Tongji Hospital, Tongji University School of Medicine Recurrent Non-small Cell Lung Cancer January 2008 Phase 1
NCT00452920 University of Miami Cervical Cancer September 2003 Phase 1|Phase 2
NCT02016417 Cancer Hospital of Guangxi Medical University Nasopharyngeal Carcinoma May 2014 Phase 2
NCT02099396 China Association of Osteosarcoma Chemotherapy Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma April 2014 Phase 2|Phase 3
NCT00003560 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer May 1998 Phase 2
NCT02703961 Fourth Military Medical University Cervical Cancer February 2016 Phase 3
NCT01331928 Taipei Veterans General Hospital, Taiwan Gastric Cancer January 2011 Phase 2
NCT02460367 NewLink Genetics Corporation Non-small Cell Lung Cancer|Progression of Non-small Cell Lung Cancer|Non-small Cell Lung Cancer Recurrent January 2016 Phase 1|Phase 2
NCT00270543 Far Eastern Memorial Hospital Stomach Neoplasms Phase 2
NCT00583622 M.D. Anderson Cancer Center Ovarian Cancer December 2007 Phase 2
NCT00744497 Bristol-Myers Squibb Prostatic Neoplasms October 2008 Phase 3
NCT01131429 Chinese PLA General Hospital Neoplasms, Lung|Carcinoma, Non-Small Cell Lung|Drug Therapy|Genes, EGFR June 2010 Phase 2
NCT00148668 Eric Winer, MD|Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Yale University Breast Cancer December 2003 Phase 2
NCT00003908 Southwest Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer November 1999 Phase 2
NCT02283983 Centre Hospitalier Departemental Vendee Breast Neoplasms December 2014
NCT00774241 Hoffmann-La Roche Breast Cancer January 2010 Phase 4
NCT01256567 Eli Lilly and Company Breast Cancer|Metastatic Breast Cancer December 2010 Phase 1
NCT00006104 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer September 1998 Phase 2
NCT01907529 Hebei Medical University Fourth Hospital Stage III Breast Cancer August 2018 Phase 2|Phase 3
NCT00482807 University of Nebraska|National Cancer Institute (NCI) Prostate Cancer August 2004 Phase 1
NCT00309985 ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Metastatic Hormone-sensitive Prostate Cancer July 2006 Phase 3
NCT00376792 Scandinavian Prostate Cancer Group|National Cancer Institute (NCI) Prostate Cancer October 2005 Phase 3
NCT00452985 Sanofi Ovarian Neoplasms February 2002
NCT02395172 EMD Serono Research & Development Institute, Inc.|Merck KGaA|EMD Serono Carcinoma, Non-Small-Cell Lung March 2015 Phase 3
NCT00006120 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Breast Cancer May 2000 Phase 2
NCT01660542 Yonsei University Locally Advanced Breast Cancer April 2011 Phase 4
NCT00352378 National Cancer Center, Korea Breast Cancer June 2002 Phase 3
NCT00005857 City of Hope Medical Center|National Cancer Institute (NCI) Prostate Cancer August 2000 Phase 2
NCT00434668 University Hospital, Antwerp|Universiteit Antwerpen|Sanofi Non-small Cell Lung Cancer December 2005 Phase 2
NCT01069081 Fudan University|Istituto Superiore di Sanità Breast Cancer|Metastasis, Neoplasm August 2009 Phase 2
NCT00471432 NCIC Clinical Trials Group|Canadian Cancer Trials Group Bladder Cancer|Breast Cancer|Kidney Cancer|Lung Cancer|Ovarian Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific March 2003 Phase 1
NCT02450539 Eli Lilly and Company Non-Small Cell Lung Cancer Stage IV August 2015 Phase 2
NCT00006682 Washington Hospital Center|National Cancer Institute (NCI) Breast Cancer February 2000 Phase 2
NCT00651326 NCIC Clinical Trials Group|Canadian Cancer Trials Group Prostate Cancer March 2008 Phase 3
NCT00040807 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer October 2002 Phase 2
NCT00593697 Finnish Breast Cancer Group Breast Neoplasms January 2008 Phase 3
NCT00425191 Sanofi Non-small Cell Lung Cancer July 2002 Phase 2
NCT00088933 National Cancer Institute (NCI) Extensive Stage Small Cell Lung Cancer|Recurrent Colon Cancer|Recurrent Non-small Cell Lung Cancer|Recurrent Rectal Cancer|Recurrent Small Cell Lung Cancer|Stage IV Colon Cancer|Stage IV Non-small Cell Lung Cancer|Stage IV Rectal Cancer June 2004 Phase 1
NCT00186277 Stanford University|Sanofi-Synthelabo Bladder Cancer December 2003 Phase 2
NCT01596868 Fourth Military Medical University Nasopharyngeal Squamous Cell Carcinoma|Toxicity Due to Radiotherapy May 2012 Phase 2
NCT02685657 Russian Academy of Medical Sciences|Russian Society of Clinical Oncology Triple Negative Breast Cancer September 2016 Phase 2
NCT00003781 OHSU Knight Cancer Institute Pain|Prostate Cancer December 1998 Phase 2
NCT00537381 Centocor, Inc. Prostatic Neoplasms May 2007 Phase 2
NCT00868998 Columbia University Biliary Cancer August 2005 Phase 2
NCT00365365 Sanofi Breast Cancer August 2006 Phase 2
NCT02465736 Sun Yat-sen University Esophageal Squamous Cell Carcinoma|Esophageal Cancer|Oesophageal Cancer July 2015 Phase 3
NCT00058253 National Cancer Institute (NCI) Recurrent Prostate Cancer|Stage IV Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific February 2003 Phase 1
NCT00535509 King Faisal Specialist Hospital & Research Center Breast Cancer June 2007
NCT00087165 Princess Margaret Hospital, Canada|National Cancer Institute (NCI) Prostate Cancer January 2005 Phase 2
NCT01448759 Institut Curie Tumors October 2011
NCT00493649 US Oncology Research|Sanofi Breast Cancer June 2007 Phase 2
NCT01497925 Polaris Group Solid Tumors|Prostate Cancer May 2011 Phase 1
NCT00148122 University of Michigan Cancer Center Head and Neck Cancer November 2002 Phase 2
NCT00331097 National Cancer Institute, Naples Breast Cancer July 2003 Phase 3
NCT01868022 GlaxoSmithKline Cancer October 9, 2013 Phase 1
NCT00102505 Pharmacyclics LLC. Non-Small-Cell Lung Carcinoma|Carcinoma, Bronchogenic November 2004 Phase 1
NCT01359397 The Netherlands Cancer Institute Metastatic Gastric Cancer|Adenocarcinoma of the Gastro-oesophageal Junction March 2011 Phase 2
NCT00138242 Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer December 2004 Phase 2
NCT01748500 University Health Network, Toronto Prostate Cancer January 2013 Phase 2
NCT01525771 Asan Medical Center Stage IV Gastric Cancer With Metastasis February 2011 Phase 1|Phase 2
NCT00096304 Medical University of South Carolina|National Cancer Institute (NCI) Prostate Cancer June 2004 Phase 1
NCT00313456 Agennix Tumors|Prostate Cancer March 2006 Phase 1
NCT00515762 Hospital San Carlos, Madrid Alopecia|Breast Cancer May 2007 Phase 2
NCT01400555 Cougar Biotechnology, Inc. Prostate Neoplasms|Prostate Cancer September 1, 2011 Phase 1
NCT00966706 IRCCS San Raffaele Pancreatic Cancer June 2005 Phase 2
NCT00066885 Novacea|Aventis Pharmaceuticals Carcinoma, Non-Small-Cell Lung June 2003 Phase 1|Phase 2
NCT00121992 Spanish Breast Cancer Research Group|Sanofi Breast Neoplasms June 1999 Phase 3
NCT00448682 University of Miami Gastric Cancer June 2005 Phase 2
NCT00077311 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Anemia|Drug/Agent Toxicity by Tissue/Organ|Lung Cancer|Neutropenia August 2004 Phase 2
NCT00932893 Pfizer Carcinoma, Non-Small-Cell Lung September 2009 Phase 3
NCT00293371 University of California, San Francisco|National Cancer Institute (NCI) Prostate Cancer February 2005 Phase 1|Phase 2
NCT00217568 Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI) Ovarian Cancer|Peritoneal Cavity Cancer May 2005 Phase 2
NCT00281970 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer August 2004 Phase 2
NCT02402842 Centre Hospitalier Universitaire de Besancon Anal Canal Carcinoma September 2014 Phase 2
NCT00499122 University of Miami Breast Cancer October 6, 2008 Phase 2
NCT00436839 Sanofi Prostatic Neoplasms January 2007 Phase 3
NCT00015886 Wake Forest University Health Sciences|National Cancer Institute (NCI) Breast Cancer January 1997 Phase 2
NCT00238615 Stanford University|Aventis Pharmaceuticals Lung Cancer|Carcinoma, Non-Small-Cell Lung March 2003 Phase 2
NCT00026156 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer November 2001 Phase 2
NCT00004864 Montefiore Medical Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific July 1999 Phase 1
NCT00769470 Translational Oncology Research International|National Cancer Institute (NCI)|University of California, Los Angeles Breast Cancer April 2009 Phase 2
NCT00415116 The Cleveland Clinic|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific August 2004 Phase 1
NCT00271323 Sanofi Non-Small-Cell Lung Carcinoma May 2005 Phase 2
NCT00186420 Stanford University|Aventis Pharmaceuticals Prostate Cancer July 2003 Phase 2
NCT00073983 Sarcoma Alliance for Research through Collaboration Sarcoma October 2006 Phase 2
NCT00209716 Hokkaido Gastrointestinal Cancer Study Group|Hokkaido University Hospital Esophageal Cancer December 2003 Phase 1|Phase 2
NCT02551055 Millennium Pharmaceuticals, Inc.|Takeda Neoplasms, Advanced or Metastatic September 2015 Phase 1
NCT01254279 Sanofi Prostate Cancer Metastatic December 2010 Phase 3
NCT01065870 Columbia University Pancreatic Cancer Stage II|Pancreatic Cancer Stage III December 2009 Phase 2|Phase 3
NCT01487720 Asan Medical Center Prostate Cancer October 2008 Phase 2
NCT00333775 Hoffmann-La Roche Breast Cancer March 2006 Phase 3
NCT02776436 Leiden University Medical Center Breast Cancer|Prostate Cancer January 2016 Phase 1
NCT02256436 Merck Sharp & Dohme Corp. Urothelial Cancer October 22, 2014 Phase 3
NCT00266838 Universitaire Ziekenhuizen Leuven Epiphora July 2006 Phase 1
NCT00005868 European Organisation for Research and Treatment of Cancer - EORTC Lung Cancer March 2000 Phase 2
NCT00002866 NCIC Clinical Trials Group|Canadian Cancer Trials Group Breast Cancer|Neutropenia August 1996 Phase 1
NCT00326378 Samsung Medical Center|Sanofi Carcinoma, Non-Small-Cell Lung October 2005 Phase 3
NCT00004884 European Organisation for Research and Treatment of Cancer - EORTC Pancreatic Cancer July 1999 Phase 2
NCT01565109 Institut Sainte Catherine Gastric Adenocarcinoma March 2009 Phase 2
NCT00165464 Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital|Aventis Pharmaceuticals Esophageal Cancer|Gastric Cancer|GE Junction Cancer August 2001 Phase 2
NCT00011414 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Wilms' Tumor|Sarcoma|Adenaocortical Carcinoma|Refractory Cancer|Coldrhood Cancer February 15, 2001 Phase 1
NCT01012297 National Cancer Institute (NCI) Recurrent Uterine Corpus Sarcoma|Stage IIIA Uterine Sarcoma|Stage IIIB Uterine Sarcoma|Stage IIIC Uterine Sarcoma|Stage IVA Uterine Sarcoma|Stage IVB Uterine Sarcoma|Uterine Corpus Leiomyosarcoma November 2009 Phase 3
NCT01362374 Genentech, Inc. Neoplasms July 11, 2011 Phase 1
NCT00003562 Hope Cancer Institute, Inc.|National Cancer Institute (NCI) Lung Cancer July 1998 Phase 2
NCT00911820 Dana-Farber Cancer Institute|Massachusetts General Hospital|SCRI Development Innovations, LLC|Texas Oncology Cancer Center|Genentech, Inc. Esophageal Cancer|Gastric Cancer|Stomach Cancer July 2009 Phase 2
NCT01204697 Hoffmann-La Roche Non-Squamous Non-Small Cell Lung Cancer November 2010 Phase 2
NCT00083005 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Prostate Cancer March 2004 Phase 2
NCT00436293 Sanofi Nasopharyngeal Neoplasms December 2002 Phase 2
NCT00514267 Astellas Pharma Inc Prostate Cancer|Tumors May 2007 Phase 1|Phase 2
NCT02586025 Hoffmann-La Roche Breast Cancer March 14, 2016 Phase 3
NCT00869258 Columbia University Pancreatic Cancer Stage IVA June 2005 Phase 2
NCT00074139 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer September 2003 Phase 1
NCT01073683 Rabin Medical Center|Davidoff Cancer Center Larynx Cancer April 2010 Phase 2
NCT01879085 Melissa Burgess, MD|Merck Sharp & Dohme Corp.|University of Pittsburgh Sarcoma June 2013 Phase 1|Phase 2
NCT00637910 Fatebenefratelli and Ophthalmic Hospital|Mario Negri Institute for Pharmacological Research|Niguarda Hospital Non Small Cell Lung Cancer (NSCLC) November 2007 Phase 3
NCT00554918 University Hospital Birmingham|National Cancer Institute (NCI) Metastatic Cancer|Prostate Cancer February 2005 Phase 2
NCT02625441 Helsinki University Central Hospital Breast Cancer December 2015 Phase 3
NCT01216124 Fudan University|Chinese Anti-Cancer Association Triple Negative Local Advanced Breast Cancer
NCT02897050 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Breast Cancer September 2016 Phase 2
NCT00398489 Technische Universität München|National Cancer Institute (NCI) Breast Cancer October 2006 Phase 2
NCT00193115 SCRI Development Innovations, LLC|Aventis Pharmaceuticals Breast Cancer March 2004 Phase 2
NCT00576901 Hoffmann-La Roche Breast Cancer November 2007 Phase 2
NCT00189137 University of Michigan Cancer Center Sarcoma, Soft Tissue August 2004 Phase 2
NCT01640860 Chonnam National University Hospital|Sanofi Esophageal Cancer December 2007
NCT00459836 Proacta, Incorporated Unspecified Adult Solid Tumor, Protocol Specific February 2007 Phase 1
NCT00391092 Hoffmann-La Roche Breast Cancer September 2006 Phase 3
NCT00379015 Translational Research Informatics Center, Kobe, Hyogo, Japan Breast Cancer January 2006 Phase 2
NCT00416533 Wake Forest University Health Sciences|National Cancer Institute (NCI) Prostate Cancer August 2004 Phase 2
NCT00242762 AstraZeneca Head and Neck Cancer July 2003 Phase 2
NCT00321334 Chinese Society of Lung Cancer Non-small Cell Lung Cancer March 2006 Phase 3
NCT00676650 Pfizer Prostatic Neoplasms July 2008 Phase 3
NCT01547741 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer April 2012 Phase 3
NCT00402545 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Bristol-Myers Squibb Head and Neck Neoplasms January 2007 Phase 1
NCT00004264 University of Wisconsin, Madison|National Cancer Institute (NCI) Drug/Agent Toxicity by Tissue/Organ|Lung Cancer July 1997 Phase 1|Phase 2
NCT01186731 INSYS Therapeutics Inc Pancreatic Cancer April 2010 Phase 2
NCT01588431 Anand B. Karnad|The University of Texas Health Science Center at San Antonio Carcinoma, Squamous Cell of Head and Neck December 2011 Phase 2
NCT00046826 Whittingham Cancer Center|National Cancer Institute (NCI) Prostate Cancer September 2001 Phase 2
NCT01285453 Novartis Pharmaceuticals|Novartis Advanced or Recurrent Solid Tumors March 2009 Phase 1
NCT00811447 Sanofi Stomach Neoplasms November 2008 Phase 3
NCT00568971 Fudan University Gastric Cancer April 2007 Phase 2
NCT00261703 Sanofi Head and Neck Neoplasms December 2002 Phase 2|Phase 3
NCT02997332 Gustave Roussy, Cancer Campus, Grand Paris|French National Cancer Institute Head and Neck Cancers March 30, 2017 Phase 1
NCT01536223 Zhejiang Cancer Hospital|Second Affiliated Hospital, School of Medicine, Zhejiang University|Zhejiang University|Zhejiang Provincial People’s Hospital|Sir Run Run Shaw Hospital|Wenzhou Medical University Chemoradiation|Nasopharyngeal Carcinoma April 2012 Phase 3
NCT00139243 Dana-Farber Cancer Institute|Sanofi|Brigham and Women's Hospital|Massachusetts General Hospital|Beth Israel Deaconess Medical Center Squamous Cell Carcinoma|Carcinoma of Head and/or Neck October 1997 Phase 1|Phase 2
NCT01533207 Gynecologic Oncology Group|National Cancer Institute (NCI) Stage I Uterine Sarcoma|Uterine Corpus Leiomyosarcoma June 2012 Phase 3
NCT01188408 INSYS Therapeutics Inc Prostate Cancer June 2010 Phase 2
NCT00310154 Wake Forest University Health Sciences|National Cancer Institute (NCI) Lung Cancer November 2003 Phase 1
NCT00449020 University of Miami Lung Cancer January 2004 Phase 2
NCT01774578 NewLink Genetics Corporation Non-small Cell Lung Cancer|Progression of Non-small Cell Lung Cancer|Non-small Cell Lung Cancer Recurrent February 2013 Phase 2|Phase 3
NCT00068341 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)|Aventis Pharmaceuticals|Genentech, Inc. Breast Cancer July 2003 Phase 2
NCT00004066 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Ovarian Cancer|Sarcoma|Small Intestine Cancer June 1999 Phase 2
NCT00620971 Hellenic Oncology Research Group|University Hospital of Crete Non Small Cell Lung Cancer January 2008 Phase 2
NCT01957436 UNICANCER|Janssen-Cilag Ltd.|European Organisation for Research and Treatment of Cancer - EORTC|Ipsen Prostate Cancer Adenocarcinoma Metastatic October 2013 Phase 3
NCT03101046 UNICANCER|National Cancer Institute, France|Institut du Cancer de Montpellier - Val d'Aurelle|Institut Bergonié Prostate Carcinoma|Castration-resistant Prostate Cancer|Circulating Tumor Cells|Chemotherapy October 1, 2017 Phase 2
NCT00418704 Groupe Francais De Pneumo-Cancerologie|Sanofi|Chugai Pharma USA Non Small Cell Lung Cancer May 2006 Phase 2
NCT01605916 AstraZeneca Neoplasms,|Metastatic Cancer,|Non-Small Cell Lung Cancer|Advanced Solid Malignancies June 2012 Phase 1
NCT00155259 National Taiwan University Hospital Breast Cancer October 2004 Phase 2
NCT00430001 Danish Breast Cancer Cooperative Group|Hoffmann-La Roche|Sanofi Breast Cancer May 2005 Phase 3
NCT00090610 Duke University|Aventis Pharmaceuticals Ovarian Cancer October 2003 Phase 2
NCT02479178 BIND Therapeutics Urothelial Carcinoma|Cholangiocarcinoma|Cervical Cancer|Squamous Cell Carcinoma of Head and Neck June 2015 Phase 2
NCT00510107 Gachon University Gil Medical Center|Sanofi Stomach Neoplasm|Stage IV|Recurrent July 2007 Phase 2
NCT00184028 University of Southern California|Sanofi Carcinoma of the Head and Neck September 2004 Phase 2
NCT00569673 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer March 2008 Phase 2
NCT01478308 New Mexico Cancer Care Alliance Prostate Cancer June 2011 Phase 2
NCT00216008 H. Lee Moffitt Cancer Center and Research Institute|Aventis Pharmaceuticals Esophageal Adenocarcinomas|Adenocarcinomas of the Gastroesophageal Junction July 2005 Phase 2
NCT00101127 Gynecologic Oncology Group|National Cancer Institute (NCI) Sarcoma December 2003 Phase 2
NCT00191672 Eli Lilly and Company Breast Neoplasms December 2003 Phase 2
NCT02870699 Institut de Cancérologie de Lorraine|Clinact Breast Carcinoma October 2011
NCT00104715 UNICANCER|National Cancer Institute (NCI) Prostate Cancer October 2004 Phase 3
NCT02003209 National Cancer Institute (NCI) Estrogen Receptor Positive|HER2/Neu Positive|Progesterone Receptor Positive|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer January 15, 2014 Phase 3
NCT01461746 Asan Medical Center|Boryung Pharmaceutical Co., Ltd Endometrial Cancer October 2011 Phase 2
NCT00625937 Yonsei University|National Cancer Institute (NCI) Head and Neck Cancer November 2006 Phase 2
NCT00845910 Hoffmann-La Roche Breast Cancer May 2009 Phase 2
NCT00431080 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer August 2004 Phase 3
NCT03117257 Guiyang Medical University Locally Advanced Head and Neck Squamous Cell Carcinoma August 19, 2016 Phase 2
NCT00052845 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Prostate Cancer November 2002 Phase 2
NCT02975934 Clovis Oncology, Inc.|Foundation Medicine Metastatic Castration Resistant Prostate Cancer January 2017 Phase 3
NCT00485979 Sanofi Breast Neoplasms June 2007 Phase 2
NCT00288080 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Prostate Cancer December 2005 Phase 3
NCT00119314 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Carcinoma of Unknown Primary July 2004 Phase 2
NCT01558011 National Health Research Institutes, Taiwan|Taipei Veterans General Hospital, Taiwan|Tri-Service General Hospital|Mackay Memorial Hospital|National Cheng-Kung University Hospital Gastric Adenocarcinoma March 2012 Phase 2
NCT01312350 Samsung Medical Center Hypopharyngeal Cancer November 2010 Phase 2
NCT00524459 Roswell Park Cancer Institute|National Cancer Institute (NCI) Breast Cancer May 2007 Phase 2
NCT02345772 Western Regional Medical Center HER2-positive Breast Cancer|ER-positive Breast Cancer July 2014
NCT01144897 University of Iowa Castrate Resistant Prostate Cancer|Prostate Cancer June 2010 Phase 1
NCT02088515 Jiangsu Simcere Pharmaceutical Co., Ltd. Squamous Cell Carcinoma December 2013 Phase 4
NCT00445861 Swiss Group for Clinical Cancer Research Esophageal Cancer January 2007 Phase 1|Phase 2
NCT00390676 Adherex Technologies, Inc.|US Oncology Research Neoplasms November 2006 Phase 1
NCT00796458 A.O.U. San Giovanni Battista di Torino, Italy|National Cancer Institute (NCI) Pain|Prostate Cancer April 2005 Phase 3
NCT00615602 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer October 2004 Phase 3
NCT00879619 John P. Fruehauf|Sanofi|University of California, Irvine Prostate Cancer|Adenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate Cancer July 2009 Phase 1|Phase 2
NCT00217529 Fred Hutchinson Cancer Research Center Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer June 2004 Phase 1|Phase 2
NCT01635465 Tianjin Medical University Cancer Institute and Hospital Anthracycline-pretreated Metastatic Breast Cancer November 2016
NCT01150513 Chinese Academy of Medical Sciences Breast Cancer June 2009 Phase 2|Phase 3
NCT00391274 Eli Lilly and Company Non-Small Cell Lung Cancer October 2006 Phase 3
NCT02512380 Chinese Academy of Medical Sciences Gastric Adenocarcinoma July 2015 Phase 3
NCT00112697 UNICANCER|National Cancer Institute (NCI) Pancreatic Cancer December 2002 Phase 2
NCT00733889 Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Merck Sharp & Dohme Corp.|Sanofi Esophageal Carcinoma December 2006 Phase 2
NCT01049425 West German Study Group|Sanofi|Amgen Primary Breast Cancer|Her2 Non-overexpressing January 2009 Phase 3
NCT01206881 Herlev Hospital|Rigshospitalet, Denmark|Odense University Hospital|Aarhus University Hospital Breast Cancer March 2009 Phase 2
NCT00319618 AstraZeneca Metastatic Breast Cancer June 2003 Phase 2
NCT00021255 Sanofi|Cancer International Research Group (CIRG) Breast Neoplasms April 2001 Phase 3
NCT00020332 National Cancer Institute (NCI) Breast Cancer October 2000 Phase 1|Phase 2
NCT00028483 Seattle Genetics, Inc. Breast Cancer October 2000 Phase 2
NCT01642771 China Breast Cancer Clinical Study Group Breast Cancer June 2012 Phase 3
NCT00720304 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer November 2007 Phase 2
NCT00214058 University of Wisconsin, Madison|Aventis Pharmaceuticals Ovarian Carcinoma|Primary Peritoneal Carcinoma August 2002 Phase 2
NCT00520676 Eli Lilly and Company Non-Small Cell Lung Cancer October 2007 Phase 3
NCT03136640 Modra Pharmaceuticals|The Netherlands Cancer Institute Castration-resistant Prostate Cancer April 26, 2017 Phase 2
NCT00359333 National Health Research Institutes, Taiwan|Mackay Memorial Hospital|Tri-Service General Hospital|China Medical University Hospital|Kaohsiung Veterans General Hospital.|Taichung Veterans General Hospital|Buddhist Tzu Chi General Hospital Sarcoma|Malignant Gastrointestinal Stromal Tumor December 2006 Phase 2
NCT00425516 Centre Jean Perrin Individualized Chemotherapy January 2007 Phase 2
NCT01234025 Ionis Pharmaceuticals, Inc. Castrate-Resistant Prostate Cancer November 2010 Phase 1|Phase 2
NCT00837265 Teva Pharmaceutical Industries Chemotherapy-induced Neutropenia August 2008 Phase 2|Phase 3
NCT00949624 Arog Pharmaceuticals, Inc. Advanced Solid Tumors December 2005 Phase 1
NCT00978549 Cambridge University Hospitals NHS Foundation Trust|National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer|Gastric Cancer|Nausea and Vomiting|Pain April 2008 Phase 3
NCT00043576 Novacea|Aventis Pharmaceuticals Prostate Cancer August 2002 Phase 2|Phase 3
NCT00623558 Seoul National University Hospital|Clinical Research Center for Solid Tumor, Korea Head and Neck Neoplasm April 2008 Phase 2
NCT00051571 Seattle Genetics, Inc. Carcinoma, Non-Small-Cell Lung Phase 2
NCT02096380 First People's Hospital of Foshan Nasopharyngeal Carcinoma May 2014 Phase 2|Phase 3
NCT00010140 International Collaborative Cancer Group|National Cancer Institute (NCI) Breast Cancer August 1997 Phase 3
NCT01459614 Sidney Kimmel Comprehensive Cancer Center Pancreatic Cancer November 2011 Phase 2
NCT01515748 Sanofi Gastric Cancer January 2012 Phase 3
NCT00282087 Sarcoma Alliance for Research through Collaboration Leiomyosarcoma|Uterine Neoplasm January 2006 Phase 2
NCT01216644 Krankenhaus Nordwest Gastric Cancer July 2010 Phase 2|Phase 3
NCT00089856 Cell Genesys Prostate Cancer July 2004 Phase 3
NCT00247481 AstraZeneca Breast Cancer September 2002 Phase 2
NCT00203502 University of Arkansas|Genentech, Inc. Breast Cancer September 2005 Phase 2
NCT00084318 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Head and Neck Cancer April 2004 Phase 2
NCT00532727 Institute of Cancer Research, United Kingdom|King's College London|Cancer Research UK|Breakthrough Breast Cancer Breast Cancer January 2008 Phase 3
NCT01812018 Peng Yuan|Chinese Academy of Medical Sciences Soft Tissue Sarcoma November 2012 Phase 2
NCT00250874 Zeneus Pharma Metastatic Breast Cancer December 2003 Phase 2
NCT02413320 University of Kansas Medical Center Triple-negative Breast Cancer July 2015 Phase 2
NCT00633568 European Lung Cancer Working Party Non-small Cell Lung Carcinoma January 2007 Phase 3
NCT00003998 University of Glasgow|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer October 1998 Phase 3
NCT00045227 National Cancer Institute (NCI) Prostate Cancer August 2002 Phase 2
NCT00005627 Dana-Farber Cancer Institute|National Cancer Institute (NCI) Prostate Cancer March 1999 Phase 1
NCT03135951 Spectrum Pharmaceuticals, Inc Breast Cancer|Pharmacokinetics May 2017 Phase 1
NCT00191152 Eli Lilly and Company Breast Cancer|Breast Neoplasms|Cancer of the Breast February 2002 Phase 3
NCT02659020 Eli Lilly and Company Soft Tissue Sarcoma March 2016 Phase 1|Phase 2
NCT00544765 German Breast Group|Roche Pharma AG|Sanofi|Amgen|University Hospital, Frankfurt Breast Cancer September 2002 Phase 3
NCT03150368 Modra Pharmaceuticals Advanced Solid Tumours May 10, 2017 Phase 1
NCT02453009 Santa Chiara Hospital Prostatic Neoplasms October 2014 Phase 2
NCT00129896 Spanish Breast Cancer Research Group|Zeneus Pharma|Sanofi|Hoffmann-La Roche|Amgen Breast Cancer January 2004 Phase 1|Phase 2
NCT00705874 Progen Pharmaceuticals Cancer May 2006 Phase 1
NCT00645866 Mayo Clinic|National Cancer Institute (NCI) Breast Cancer April 2003 Phase 2
NCT02643420 Spectrum Pharmaceuticals, Inc Neutropenia|Breast Cancer December 2015 Phase 3
NCT00190476 Japan Clinical Oncology Group|Ministry of Health, Labour and Welfare, Japan Non-small-cell Lung Cancer April 2003 Phase 3
NCT00004001 Southwest Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B|North Central Cancer Treatment Group Prostate Cancer October 1999 Phase 3
NCT02654587 OSE Immunotherapeutics|Orion Corporation, Orion Pharma Non Small Cell Lung Cancer February 2016 Phase 3
NCT01257139 Rennes University Hospital Non Small-cell Lung Cancer January 2010 Phase 3
NCT01690325 West German Study Group|Roche Pharma AG|Sanofi Breast Cancer September 2012 Phase 2
NCT00600249 Centre Jean Perrin|Merck Sharp & Dohme Corp.|Sanofi Breast Cancer January 2008 Phase 2
NCT01862081 Genentech, Inc. Breast Cancer, Non-small Lung Cancer July 16, 2013 Phase 1
NCT01928524 Per Pfeiffer|Taiho Pharmaceuticals CO Ltd.|Nordic Group BV|Odense University Hospital First-line Treatment for Patients With Non-resectable Gastric Cancer or Cancer of the Esophagus or September 2013 Phase 1
NCT01192165 GlaxoSmithKline Cancer September 2010 Phase 1
NCT02179671 AstraZeneca|Quintiles, Inc. Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV) July 2014 Phase 2
NCT01354522 Peking Union Medical College Hospital Breast Cancer May 2011 Phase 3
NCT02001506 Asan Medical Center Breast Cancer November 2012 Phase 3
NCT02802423 BioLite, Inc. Triple Negative Breast Cancer August 2016 Phase 1|Phase 2
NCT00464646 NSABP Foundation Inc|Genentech, Inc.|International Drug Development Institute Breast Cancer May 2007 Phase 2
NCT00450892 European Organisation for Research and Treatment of Cancer - EORTC|GlaxoSmithKline Breast Cancer February 2007 Phase 1|Phase 2
NCT00167401 University of Rochester Carcinoma, Non-Small-Cell Lung February 2002 Phase 2
NCT00712881 Cephalon|Teva Pharmaceutical Industries Breast Cancer October 2008 Phase 2
NCT02087176 AstraZeneca Previously Treated Non Small Cell Lung Cancer March 2014 Phase 2
NCT00117572 University of Chicago Cancer of the Pharynx|Cancer of the Larynx|Cancer of the Nasal Cavity|Paranasal Sinus Neoplasms|Cancer of the Oral Cavity November 2004 Phase 3
NCT02402712 Hoffmann-La Roche Breast Cancer May 6, 2015 Phase 3
NCT00002707 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer December 1995 Phase 3
NCT00201435 Norwegian Breast Cancer Group Breast Neoplasm March 2005 Phase 2|Phase 3
NCT00079287 Japan Multinational Trial Organization|National Cancer Institute (NCI) Lung Cancer March 2001 Phase 3
NCT00994968 Yonsei University|National Cancer Institute (NCI) Breast Cancer July 2009 Phase 2
NCT00498797 Sanofi|Genzyme, a Sanofi Company Prostate Cancer|Metastatic|Hormone Refractory December 2005 Phase 2
NCT00040547 Merck Sharp & Dohme Corp. Neoplasms June 2001 Phase 1
NCT01221753 Dana-Farber Cancer Institute Squamous Cell Carcinoma of the Head and Neck|Human Papilloma Virus July 2011 Phase 2
NCT00911352 Princess Alexandra Hospital, Brisbane, Australia Effects of Chemotherapy October 2010 Phase 2|Phase 3
NCT00082134 Genzyme, a Sanofi Company|Sanofi Hormone-refractory Prostate Cancer Phase 2
NCT03006432 Federation Francophone de Cancerologie Digestive|UNICANCER|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR) OESOPHAGO-GASTRIC CARCINOMA December 2016 Phase 3
NCT00213694 University Hospital, Rouen Metastatic Prostate Cancer November 2003 Phase 2
NCT00050674 Schwartzberg, Lee, M.D.|Amgen Non-small Cell Lung Cancer November 2001 Phase 2
NCT02105675 Sotio a.s. Prostate Cancer|Prostate Cancer Metastatic February 2012 Phase 2
NCT00155883 National Taiwan University Hospital Gastric Cancer June 2004 Phase 2
NCT02124668 Astellas Pharma Europe B.V.|Medivation, Inc.|Astellas Pharma Inc Castration-Resistant Prostate Cancer|Prostate Cancer September 30, 2014 Phase 2
NCT01126190 Teva Pharmaceutical Industries Chemotherapy-induced Neutropenia June 2010 Phase 3
NCT03102606 BeyondSpring Pharmaceuticals Inc.|Chiltern International Inc.|ICON plc Chemotherapy-induced Neutropenia March 13, 2017 Phase 2|Phase 3
NCT00003782 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer March 1999 Phase 3
NCT00477529 Celgene Corporation|Celgene Hormone Refractory Prostate Cancer April 2007 Phase 1|Phase 2
NCT01426620 James Graham Brown Cancer Center Non-small Cell Lung Cancer June 2011 Phase 2
NCT00283829 University of Washington|Sanofi Prostate Cancer September 2002 Phase 1|Phase 2
NCT01999933 Mei Shi|Fourth Military Medical University Cervical Cancer|Toxicity Due to Radiotherapy November 2013 Phase 2|Phase 3
NCT01606982 Astellas Pharma Global Development, Inc.|Medivation, Inc.|Astellas Pharma Inc Metastatic Castration-Resistant Prostate Cancer
NCT00103428 Cell Genesys Prostate Cancer August 2004 Phase 1|Phase 2
NCT02187744 Pfizer Early Breast Cancer September 23, 2014 Phase 3
NCT00072930 MedImmune LLC Prostate Cancer December 2003 Phase 2
NCT01652820 Spanish Lung Cancer Group|Aventis Pharmaceuticals Non Small-cell Lung Cancer October 2001 Phase 2
NCT01707966 Swiss Group for Clinical Cancer Research Prostate Cancer September 2012 Phase 3
NCT00285675 Novacea Androgen Independent Prostate Cancer (AIPC)|Non Small Cell Lung Cancer (NSCLC) April 2006 Phase 2
NCT01732549 Ipsen Metastatic Castrate Resistant Prostate Cancer January 2013 Phase 2
NCT00271687 AHS Cancer Control Alberta|Cross Cancer Institute Prostatic Neoplasms|Neoplasm Metastasis|Palliative Care February 2006 Phase 2
NCT00003352 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer June 1998 Phase 2
NCT00004175 Northwestern University|National Cancer Institute (NCI) Breast Cancer November 1998 Phase 2
NCT00120939 Pharmacyclics LLC. Breast Neoplasms|Ovarian Neoplasms|Prostatic Neoplasms|Lung Neoplasms|Gastrointestinal Neoplasms Phase 1
NCT01763671 Intergroupe Francophone de Cancerologie Thoracique Non-squamous Non-small Cell Lung Cancer May 2013 Phase 3
NCT00080041 Pharmacyclics LLC. Breast Neoplasms|Ovarian Neoplasms|Prostatic Neoplasms|Lung Neoplasms Phase 1
NCT00243204 Point Therapeutics Carcinoma, Non-Small Cell Lung January 2006 Phase 3
NCT00798070 Karolinska University Hospital|Swedish Breast Cancer Group|Austrian Breast & Colorectal Cancer Study Group|German Breast Group Breast Cancer February 2007 Phase 3
NCT00365417 NSABP Foundation Inc|Genentech, Inc.|Hoffmann-La Roche|International Drug Development Institute Breast Cancer August 2006 Phase 2
NCT01614938 Fudan University Nasopharyngeal Carcinoma August 2010 Phase 2
NCT01295086 Odense University Hospital|Aalborg Universitetshospital|Aarhus University Hospital|Rigshospitalet, Denmark Adenocarcinoma March 2011
NCT00017563 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Prostate Cancer September 2000 Phase 2
NCT02685111 Asan Medical Center|Kyowa Hakko Kirin Co., Ltd Breast Cancer|Neutropenia|Febrile Neutropenia February 2016 Phase 2
NCT03066154 The Netherlands Cancer Institute Prostatic Neoplasms September 2016 Phase 1
NCT00002544 Arbeitsgemeinschaft fur Internistische Onkologie|National Cancer Institute (NCI) Breast Cancer May 1993 Phase 3
NCT02035124 SCRI Development Innovations, LLC|Novartis Advanced Prostate Cancer April 2014 Phase 2
NCT01716546 Hellenic Oncology Research Group Gastric Cancer July 2011 Phase 1|Phase 2
NCT00051974 Millennium Pharmaceuticals, Inc. Non-Small Cell Lung Cancer December 2002 Phase 2
NCT00734851 Duke University|Pfizer|Sanofi Prostate Cancer December 2008 Phase 2
NCT00064636 Millennium Pharmaceuticals, Inc. Advanced Non-Small Cell Lung Cancer|Other Solid Tumors December 2002 Phase 1
NCT00165399 Dana-Farber Cancer Institute Adenocarcinoma of the Prostate|Prostate Cancer March 2004 Phase 2
NCT00252707 AstraZeneca Non-Small Cell Lung Cancer September 2003 Phase 3
NCT00194740 University of Washington|Aventis Pharmaceuticals Breast Neoplasm November 1997 Phase 2
NCT00006215 Amgen|National Cancer Institute (NCI) Lung Cancer October 1999 Phase 2
NCT01479504 Guangxi Medical University|People's Hospital of Guangxi|303rd Hospital of the People's Liberation Army|Nanning Second People's Hospital|Guangxi Traditional Chinese Medical University|Guilin Medical College|Guangxi Naxishan Hospital|Liuzhou Worker's Hospital|Liuzhou People's Hospital|Liuzhou Hospital of Traditional Chinese Medicine|Liuzhou Cancer Hospital|Liuzhou Railway hospital|First People's Hospital of Yulin|The Red Cross hospital of YuLin|Guigang People's Hospital|The Red Cross hospital of Wuzhou Nasopharyngeal Carcinoma November 2011 Phase 3
NCT00974311 Medivation, Inc.|Astellas Pharma Inc Castration-Resistant Prostate Cancer September 2009 Phase 3
NCT02776163 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Salivary Gland Tumors|Head and Neck Cancer June 2016 Phase 2
NCT00094822 Amgen Lung Cancer|Non-Small Cell Lung Cancer July 2003
NCT00824811 M.D. Anderson Cancer Center|Allergan Epiphora June 2009 Phase 2
NCT01605227 Exelixis Prostate Cancer|Castration Resistant Prostate Cancer|Pain|Prostatic Neoplasms June 2012 Phase 3
NCT00110214 National Cancer Institute (NCI) Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer April 2005 Phase 3
NCT00374985 Johannes Gutenberg University Mainz Esophageal Neoplasms|Stomach Neoplasms October 2005 Phase 1|Phase 2
NCT00111618 Antisoma Research Prostate Cancer May 2005 Phase 2
NCT00251498 Veeda Oncology|Bristol-Myers Squibb Carcinoma, Non-Small-Cell Lung Phase 2
NCT01192230 Fudan University Carcinoma, Non-Small-Cell Lung June 2009 Phase 2
NCT00419536 Novartis Pharmaceuticals|Novartis Hormone Refractory Prostate Cancer Disease May 2006 Phase 1
NCT01240642 Novartis Pharmaceuticals|Novartis Metastatic Cancer With Impaired Renal Function|Metastatic Cancer With Normal Renal Function January 2010 Phase 1
NCT00247988 University of Saskatchewan|Sanofi Platinum Sensitive Relapsed Ovarian Cancer October 2003 Phase 2
NCT00031629 Gynecologic Oncology Group|National Cancer Institute (NCI) Recurrent Uterine Corpus Sarcoma|Uterine Corpus Leiomyosarcoma January 2005 Phase 2
NCT02642458 University Hospital Tuebingen Metastatic Breast Cancer March 2016
NCT01462149 Asan Medical Center|Sanofi Advanced Ovarian Cancer October 2011 Phase 2
NCT01461759 Asan Medical Center|Boryung Pharmaceutical Co., Ltd Advanced or Recurrent Endometrial Cancer October 2011 Phase 2
NCT02182219 Boehringer Ingelheim Prostatic Neoplasms November 2005 Phase 1
NCT00064610 Millennium Pharmaceuticals, Inc. Prostatic Neoplasms December 2002 Phase 1|Phase 2
NCT00209690 Hokkaido Gastrointestinal Cancer Study Group|Hokkaido University Hospital Esophageal Cancer October 2003 Phase 1|Phase 2
NCT01040624 University of Florida Prostate Cancer December 2009
NCT00082472 Zivena NSCLC January 2004 Phase 1|Phase 2
NCT00927589 Genentech, Inc. Solid Cancers July 2009 Phase 1
NCT00319800 Gachon University Gil Medical Center Non-Small Cell Lung Cancer February 2006 Phase 2
NCT02961257 Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie Prostate Cancer Metastatic May 5, 2017 Phase 3
NCT02718482 Italian Sarcoma Group OSTEOSARCOMA April 2016 Phase 2
NCT01443078 Memorial Sloan Kettering Cancer Center|Eli Lilly and Company|United States Department of Defense Lung Cancer October 2011 Phase 2
NCT01695135 Janssen Research & Development, LLC Prostate Neoplasms August 9, 2012 Phase 3
NCT01154920 M.D. Anderson Cancer Center|Dana-Farber Cancer Institute Head and Neck Squamous Cell Carcinoma July 2010 Phase 2
NCT00911716 Cancer Trials Ireland Breast Cancer October 2008
NCT01469338 University of Southern California|National Cancer Institute (NCI)|Sanofi Diarrhea|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate Cancer July 2012 Phase 2
NCT01425736 Wei Guo|Sun Yat-sen University|Shanghai 9th People's Hospital Head and Neck Squamous Cell Carcinoma January 2009 Phase 2
NCT01574716 Morphotek Metastatic Soft Tissue Sarcoma May 2012 Phase 2
NCT00268372 Southwest Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer December 2005 Phase 3
NCT01084330 Novartis Pharmaceuticals|Novartis Advanced Gastric Cancer|Gastro-esophageal Junction Cancer April 2010 Phase 2
NCT00183924 University of Southern California|Aventis Pharmaceuticals Prostate Adenocarcinoma March 2001 Phase 2
NCT00985998 Biotech Pharmaceutical Co., Ltd. Non-small Cell Lung Cancer September 2009 Phase 1
NCT00687297 PrECOG, LLC.|AstraZeneca Lung Cancer|Non Small Cell Lung Cancer April 2008 Phase 2
NCT02324543 Sidney Kimmel Comprehensive Cancer Center Metastatic Pancreatic Adenocarcinoma February 2015 Phase 1|Phase 2
NCT01472029 AIO-Studien-gGmbH|Roche Pharma AG Adenocarcinoma of the Gastroesophageal Junction|Adenocarcinoma of the Stomach December 2011 Phase 2
NCT00050167 M.D. Anderson Cancer Center|Roche Pharma AG Breast Cancer November 2002 Phase 1
NCT01207011 Sumitomo Dainippon Pharma Co., Ltd. Lung Cancer October 2010 Phase 3
NCT00055731 UNICANCER|National Cancer Institute (NCI) Prostate Cancer November 2002 Phase 3
NCT03067792 Yonsei University Inoperable Gastric Cancer December 2014 Phase 3
NCT01869192 University of Colorado, Denver Malignant Neoplasm of Female Breast March 5, 2003 Phase 2
NCT00499694 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Prostate Cancer October 2007
NCT00129935 Spanish Breast Cancer Research Group|Sanofi|Hoffmann-La Roche|Pfizer Breast Cancer February 2004 Phase 3
NCT00475670 Hoffmann-La Roche Breast Cancer October 2005 Phase 2
NCT01557959 Wake Forest University Health Sciences|National Cancer Institute (NCI)|OSI Pharmaceuticals Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer July 2007 Phase 2
NCT02115204 West German Study Group|AGO Germany Breast Cancer June 2000 Phase 3
NCT01604863 Human Genome Sciences Inc., a GSK Company|GlaxoSmithKline Cancer June 2012 Phase 1
NCT00313690 University of Southern California Lung Cancer April 2006 Phase 1|Phase 2
NCT00721513 Wake Forest University Health Sciences|National Cancer Institute (NCI) Head and Neck Cancer September 2008 Phase 2
NCT00763646 McGill University Gastric Junction Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma April 2007 Phase 2
NCT01058759 Hannover Medical School|Hannover Clinical Trial Center GmbH Non-small Cell Lung Cancer November 2009 Phase 3
NCT00003810 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Pancreatic Cancer April 1999 Phase 2
NCT01792050 NewLink Genetics Corporation Metastatic Breast Cancer February 2013 Phase 2
NCT01260688 National Cancer Institute (NCI) Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer October 2010 Phase 2
NCT01795703 Janssen Research & Development, LLC Prostate Cancer June 2012 Phase 2
NCT00771563 University Hospital, Antwerp|Universiteit Antwerpen Non-Small Cell Lung Cancer June 2008 Phase 3
NCT02290145 Shanghai Jiao Tong University School of Medicine Mouth Neoplasms|Carcinoma, Squamous Cell December 2014 Phase 2
NCT02076594 Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente|Regione Lombardia Locally Advanced Unresectable Gastric Cancer|Metastatic Gastric Cancer January 2013 Phase 3
NCT00776724 National Taiwan University Hospital Breast Cancer|Chemotherapy November 2008 Phase 3
NCT00835471 Dutch Society of Physicians for Pulmonology and Tuberculosis Carcinoma, Non-Small-Cell Lung March 2009 Phase 2
NCT02485691 Sanofi Prostate Cancer Metastatic November 2015 Phase 4
NCT00474383 Cougar Biotechnology, Inc. Prostate Neoplasms November 2006 Phase 2
NCT01174368 The Rogosin Institute Prostate Cancer June 2010 Phase 2
NCT00045448 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific April 2002 Phase 1
NCT01083615 OncoGenex Technologies|Teva Pharmaceuticals USA Castrate-Resistant Prostate Cancer|Hormone Refractory Prostate Cancer March 2010 Phase 3
NCT01160705 Cancer Trials Ireland Metastatic Cancer|Prostate Cancer November 2009
NCT00176527 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Prostate Cancer November 2002 Phase 2
NCT02307227 Centro di Riferimento Oncologico - Aviano Breast Neoplasms April 2006 Phase 2
NCT00406302 Wolfgang Hilbe|Merck Sharp & Dohme Corp.|Sanofi|TAKO - Tiroler Arbeitskreis Onkologie|Medical University of Vienna Carcinoma, Non-small-cell Lung January 2007 Phase 2
NCT00636441 Duke University|United States Department of Defense Early-Stage Breast Cancer April 2008 Phase 2
NCT01424709 Tongji University Non-small Cell Lung Cancer December 2010 Phase 2
NCT00256841 Clinical Oncology Research Associates Carcinoma, Non-Small-Cell Lung September 2005 Phase 1|Phase 2
NCT00638690 Cougar Biotechnology, Inc. Prostatic Neoplasms May 2008 Phase 3
NCT01051570 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Prostate Cancer February 2010 Phase 2
NCT01977209 Third Military Medical University Non-small Cell Lung Cancer September 2013 Phase 3
NCT02670603 Samsung Medical Center Breast Cancer|Docetaxel Chemotherapy August 2015
NCT01168973 Eli Lilly and Company|ImClone LLC Non-Small Cell Lung Cancer December 2010 Phase 3
NCT00242983 National Hospital Organization Kinki-chuo Chest Medical Center|National Cancer Institute (NCI) Lung Cancer April 2004
NCT01530295 Hanjong Ahn|Asan Medical Center Prostate Cancer July 2008
NCT02285543 Shanghai Jiao Tong University School of Medicine Mouth Neoplasms|Carcinoma, Squamous Cell December 2014 Phase 2
NCT00828386 Groupe Oncologie Radiotherapie Tete et Cou Nasopharyngeal Cancers January 2009 Phase 3
NCT01338753 Clinica Universidad de Navarra, Universidad de Navarra|Roche Farma, S.A Breast Neoplasms October 2009 Phase 2
NCT01503905 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Breast Cancer Nos Premenopausal December 2011
NCT03177174 Luo yanrong|Chinese PLA General Hospital Drug-Related Side Effects and Adverse Reactions June 12, 2017
NCT01783587 Dana-Farber Cancer Institute|National Comprehensive Cancer Network Squamous Cell Carcinoma of the Head and Neck February 2013 Phase 1
NCT00766246 Pharmatech|Genentech, Inc.|Sanofi Non-small Cell Lung Cancer Stage IIIB|Non-small Cell Lung Cancer Stage IV October 2008 Phase 2
NCT00174629 Sanofi Lung Neoplasms June 2001 Phase 3
NCT00284778 University Hospital, Limoges|Groupe Francais De Pneumo-Cancerologie Carcinoma, Non-Small-Cell Lung February 2006 Phase 3
NCT01142778 Hoffmann-La Roche Breast Cancer May 2010 Phase 2
NCT01289522 Groupe Oncologie Radiotherapie Tete et Cou|Gustave Roussy, Cancer Campus, Grand Paris Squamous Cell Head and Neck Carcinoma|Recurrent or Metastatic Disease September 2009 Phase 2
NCT01884259 Arbeitsgemeinschaft medikamentoese Tumortherapie Squamous Cell Carcinoma of the Hypopharynx Stage III|Squamous Cell Carcinoma of the Hypopharynx Stage IV|Squamous Cell Carcinoma of the Larynx Stage III|Squamous Cell Carcinoma of the Larynx Stage IV|Squamous Cell Carcinoma of the Oropharynx Stage III|Squamous Cell Carcinoma of the Oropharynx Stage IV|Squamous Cell Carcinoma of the Oral Cavity Stage III|Squamous Cell Carcinoma of the Oral Cavity Stage IV May 2013 Phase 2
NCT00005810 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Prostate Cancer March 2000 Phase 2
NCT02613026 307 Hospital of PLA Breast Neoplasms July 2009 Phase 3
NCT00617968 Sanofi Breast Neoplasms October 2003 Phase 2
NCT00559754 Hoffmann-La Roche Breast Cancer December 2007 Phase 2
NCT03114280 Centre Antoine Lacassagne Head and Neck Squamous Cell Carcinoma (HNSCC) June 2017 Phase 2
NCT01314833 Fudan University|Chinese Anti-Cancer Association Breast Cancer June 2010 Phase 3
NCT00085826 Astellas Pharma Inc|OSI Pharmaceuticals Non-Small Cell Lung Cancer April 2001 Phase 3
NCT00049998 GlaxoSmithKline Non-Small-Cell Lung Cancer October 2001 Phase 3
NCT00003953 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer February 1999 Phase 2
NCT01889303 Wuhan University Gastric Cancer May 2013 Phase 2
NCT01542931 Shanghai Jiao Tong University School of Medicine Stage III Oral Cavity Squamous Cell Carcinoma|Stage IVA Oral Cavity Squamous Cell Carcinoma January 2008 Phase 2|Phase 3
NCT02177552 Rigshospitalet, Denmark Esophageal Neoplasms|Stomach Neoplasms June 2014 Phase 2
NCT00314977 Radboud University|Sanofi|Amgen Breast Cancer February 2006 Phase 3
NCT00251329 Cancer Research Network|Sanofi Breast Cancer May 2003 Phase 2
NCT00005060 Swiss Group for Clinical Cancer Research Gastric Cancer November 1999 Phase 3
NCT00798252 Bristol-Myers Squibb Advanced Cancer March 2009 Phase 1
NCT00411528 Novartis Pharmaceuticals|Novartis Metastatic Hormone Refractory Prostate Cancer September 2006 Phase 2
NCT02126969 University of Kentucky Head and Neck Cancer|Larynx October 2014 Phase 2
NCT02786641 Sun Yat-sen University Nasopharyngeal Carcinoma August 2016 Phase 3
NCT02512315 Sun Yat-sen University Nasopharyngeal Carcinoma August 2015 Phase 3
NCT00938470 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer|Gastric Cancer January 2010 Phase 2
NCT00508664 ClinAssess|Merck Sharp & Dohme Corp.|Sanofi|University of Leipzig Squamous Cell Carcinoma of the Hypopharynx|Larynx Carcinoma July 2007 Phase 2
NCT02963168 Kinex Pharmaceuticals Inc Solid Tumor April 20, 2017 Phase 1
NCT02324088 UNICANCER Inflammatory Breast Cancer October 2000 Phase 3
NCT00556322 Hoffmann-La Roche Non-Small Cell Lung Cancer March 2006 Phase 3
NCT00963807 National Cancer Institute (NCI) Recurrent Non-Small Cell Lung Carcinoma|Stage IB Non-Small Cell Lung Carcinoma|Stage IIA Non-Small Cell Lung Carcinoma|Stage IIB Non-Small Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer September 2009 Phase 2
NCT00014196 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer March 2001 Phase 2
NCT02111577 Sotio a.s. Metastatic Castrate Resistant Prostate Cancer April 2014 Phase 3
NCT00545688 Hoffmann-La Roche Breast Cancer June 2006 Phase 2
NCT01633541 University of Michigan Cancer Center Laryngeal Cancer March 2012 Phase 2
NCT01270373 Instituto Nacional de Cancer, Brazil|Sanofi Breast Cancer August 2010 Phase 2
NCT01222052 Martin-Luther-Universität Halle-Wittenberg|German Breast Group Breast Cancer January 2002 Phase 3
NCT02339532 UNICANCER Breast Cancer January 2015 Phase 2
NCT02419742 Hoffmann-La Roche Breast Cancer August 18, 2015 Phase 4
NCT02005549 Hoffmann-La Roche Breast Cancer February 2006 Phase 2
NCT02564263 Merck Sharp & Dohme Corp. Esophageal Carcinoma|Esophagogastric Junction Carcinoma December 1, 2015 Phase 3
NCT00794547 University of Michigan Cancer Center Non Small Cell Lung Cancer December 2008 Phase 1|Phase 2
NCT00014456 Dartmouth-Hitchcock Medical Center|National Cancer Institute (NCI) Bladder Cancer|Breast Cancer|Carcinoma of Unknown Primary|Esophageal Cancer|Gastric Cancer|Head and Neck Cancer|Lung Cancer|Melanoma (Skin)|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer|Sarcoma March 2000 Phase 1
NCT03015727 Zhejiang Cancer Hospital|Zhejiang Provincial People’s Hospital|The Central Hospital of Lishui City|Jinhua Central Hospital|First Affiliated Hospital of Wenzhou Medical Univeristy|Ningbo Medical Center Lihuili Eastern Hospital|People's Hospital of Quzhou Locally Advanced Nasopharyngeal Carcinoma December 2016 Phase 3
NCT00531271 Celgene Corporation Metastatic Breast Cancer November 2007 Phase 1|Phase 2
NCT00072618 Astellas Pharma Inc|OSI Pharmaceuticals NSCLC October 2001 Phase 1|Phase 2
NCT00003587 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer October 1998 Phase 2
NCT02953184 Jilin University Antineoplastic Combined Chemotherapy Protocols November 2016 Phase 2
NCT02157116 Duke University|Sanofi Non-small Cell Lung Cancer May 2006 Phase 2
NCT01792479 BIND Therapeutics Non-small Cell Lung Cancer April 2013 Phase 2
NCT00236899 Eli Lilly and Company Metastatic Breast Cancer (MBC) September 2005 Phase 3
NCT01812746 BIND Therapeutics CRPC|Prostate Cancer April 2013 Phase 2
NCT02815319 Ottawa Hospital Research Institute Cancer January 2017 Phase 4
NCT01245959 Sun Yat-sen University|Fudan University|West China Hospital|Huazhong University of Science and Technology|Beijing Cancer Hospital|Zhejiang Cancer Hospital|Central South University|Jiangsu Cancer Institute & Hospital|First People's Hospital of Foshan|The Third Affiliated Hospital of Harbin Medical University|Cancer Hospital of Guangxi Medical University|Jiangxi Provincial Cancer Hospital|Guangzhou Medical University Nasopharyngeal Carcinoma January 2011 Phase 3
NCT02982395 Samyang Biopharmaceuticals Corporation Non Muscle Invasive Bladder Cancer December 2016 Phase 3
NCT03001726 Shanghai Zhongshan Hospital Gastric Cancer January 2017 Phase 3
NCT00073866 Northwestern University|National Cancer Institute (NCI) Lung Cancer June 2003 Phase 1|Phase 2
NCT00005958 Amgen|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter October 1999 Phase 2
NCT00191490 Eli Lilly and Company|Aventis Pharmaceuticals Carcinoma, Non-Small-Cell Lung July 2002 Phase 2
NCT03099382 Jiangsu HengRui Medicine Co., Ltd. Esophageal Carcinoma May 10, 2017 Phase 3
NCT00004082 Beth Israel Deaconess Medical Center|National Cancer Institute (NCI) Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer July 1999 Phase 1
NCT00841828 Spanish Breast Cancer Research Group|GlaxoSmithKline Breast Cancer February 2009 Phase 2|Phase 3
NCT00003037 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lung Cancer April 1997 Phase 1|Phase 2
NCT02513342 Nanjing NingQi Medicine Science and Technology Co., Ltd. Advanced Lung Squamous Carcinoma March 2015 Phase 4
NCT00941135 Fundacion Miguel Servet|Salutis Research, SL|Unidad de Genética Clínica (Clínica Universitaria de Navarra) Laryngeal Neoplasms May 2009 Phase 2
NCT01967875 China Medical University, China Stomach Neoplasms July 2013 Phase 2
NCT01618474 Tianjin Medical University Cancer Institute and Hospital Stomach Cancer May 2012 Phase 2
NCT01149902 University of Yamanashi Head and Neck Cancer July 2010 Phase 1
NCT01891123 Sun Yat-sen University Non-small Cell Lung Cancer|Breast Cancer|Nasal Cancer June 2013
NCT01059188 Swiss Group for Clinical Cancer Research Lung Cancer January 2010 Phase 2
NCT00093795 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer October 2004 Phase 3
NCT01741753 Dana-Farber Cancer Institute Prostate Cancer November 2012 Phase 1
NCT02575547 Zhao Chong|Wuhan University|Fudan University|Fujian Cancer Hospital|Zhejiang Cancer Hospital|First Affiliated Hospital of Guangxi Medical University|The First Affiliated Hospital of Xiamen University|Cancer Hospital of Guizhou Province|Hainan People's Hospital|First People's Hospital of Foshan|Sun Yat-sen University Nasopharyngeal Carcinoma|Malnutrition May 2015
NCT00016107 National Cancer Institute (NCI) Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer June 2001 Phase 2
NCT00487786 OncoGenex Technologies Neoplasms June 2007 Phase 1
NCT00308750 Eli Lilly and Company Non-small Cell Lung Cancer March 2006 Phase 2
NCT00274287 Oncology Specialists, S.C.|Genzyme, a Sanofi Company Prostate Cancer January 2006 Phase 2
NCT02121639 University Hospital Southampton NHS Foundation Trust|AstraZeneca|Cancer Research UK Prostate Cancer January 2014 Phase 1|Phase 2
NCT00113386 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|North Central Cancer Treatment Group Lung Cancer April 2005 Phase 3
NCT00448760 University of Miami Esophageal Cancer October 2004 Phase 2
NCT01852578 Hellenic Oncology Research Group NSCLC September 2012 Phase 2
NCT02605915 Hoffmann-La Roche HER2-Positive Metastatic Breast Cancer|HER2-Negative Metastatic Breast Cancer|Locally Advanced or Early Breast Cancer December 31, 2015 Phase 1
NCT01246856 Radboud University Breast Cancer November 2010
NCT02568839 Thomas Hatschek|Karolinska University Hospital Early-Stage Breast Carcinoma|HER-2 Positive Breast Cancer November 2014 Phase 2|Phase 3
NCT02283424 Chinese PLA General Hospital Neoplasms, Therapy-Associated October 2014 Phase 4
NCT00848601 Astex Pharmaceuticals Prostate Cancer|Non-Hodgkins Lymphoma February 2009 Phase 1
NCT01487902 Asan Medical Center Castration-resistant Prostate Cancer July 2010 Phase 2
NCT00485303 Cougar Biotechnology, Inc. Prostatic Neoplasms|Prostate Cancer June 2007 Phase 2
NCT01641939 Hoffmann-La Roche Gastric Cancer September 3, 2012 Phase 2|Phase 3
NCT00193427 SCRI Development Innovations, LLC|Aventis Pharmaceuticals|Eli Lilly and Company Lung Cancer April 2004 Phase 2
NCT00012220 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Pancreatic Cancer January 2001 Phase 2
NCT00003915 University of Massachusetts, Worcester Prostate Cancer May 1999 Phase 2
NCT00816855 Fudan University Nasopharyngeal Carcinoma February 2007 Phase 2
NCT00964704 Hoffmann-La Roche Breast Cancer March 2011 Phase 2
NCT00816816 Fudan University Nasopharyngeal Carcinoma February 2007 Phase 2
NCT02478125 Sidney Kimmel Comprehensive Cancer Center|Prostate Cancer Foundation Prostate Cancer July 2015 Phase 1
NCT00096707 Threshold Pharmaceuticals Lung Cancer|Breast Cancer|Pancreatic Cancer|Head and Neck Cancer|Gastric Cancer February 2004 Phase 1
NCT00434031 National Cancer Institute, Naples Breast Cancer September 2007 Phase 2
NCT00493870 US Oncology Research|Sanofi Breast Cancer May 2007 Phase 3
NCT00630032 UNICANCER Breast Cancer September 2007 Phase 3
NCT00124566 Eisai Inc. Prostate Cancer June 2004 Phase 2
NCT00004888 National Cancer Institute (NCI) Recurrent Breast Cancer|Stage IV Breast Cancer January 2001 Phase 2
NCT02441517 Astellas Pharma Global Development, Inc.|Medivation, Inc.|Astellas Pharma Inc Metastatic Castration Resistant Prostate Cancer October 28, 2015 Phase 4
NCT01963702 Fudan University Gastric Cancer August 2012 Phase 2
NCT01003964 National Cancer Center, Korea Non Small Cell Lung Cancer February 2009 Phase 2
NCT01708993 Canadian Cancer Trials Group|Oncolytics Biotech Non Small Cell Lung Cancer October 15, 2012 Phase 2
NCT01217060 M.D. Anderson Cancer Center Esophageal Cancer October 2010 Phase 1|Phase 2
NCT00525200 Daniela Kandioler|Medical University of Vienna|Austrian Society Of Surgical Oncology Esophageal Cancer June 2007 Phase 3
NCT01784549 IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|Azienda Sanitaria Locale di Cagliari|Azienda Ospedaliera San Gerardo di Monza|Ospedale Santa Croce-Carle Cuneo|Azienda Ospedaliera S. Maria della Misericordia|Istituto Tumori Giovanni Paolo II, BARI|Azienda Ospedaliera dei Colli|Azienda Ospedaliera Santa Maria Degli Angeli|Azienda Ospedaliera San Camillo Forlanini|Azienda Ospedaliera San Giovanni Battista|Azienda Ospedaliera Universitaria Integrata Verona|Azienda Sanitaria Locale n.2 Savonese|ASL TO4, Chivasso|Azienda Provinciale per i Servizi Sanitari, Provincia Autonoma di Trento|Istituto Clinico Humanitas|Azienda Ospedaliera Sant'Andrea, Roma|Azienda Ospedaliera, Ospedale Civile di Legnano|Azienda Ospedaliera Spedali Riuniti di Livorno, Livorno Non Small Cell Lung Cancer July 2012 Phase 2
NCT02479217 Hoffmann-La Roche Metastatic Breast Cancer, Colon Cancer July 2006
NCT00270894 Accelerated Community Oncology Research Network|Aventis Pharmaceuticals Breast Neoplasm November 2005 Phase 2
NCT00149214 Eli Lilly and Company Breast Cancer September 2005 Phase 2
NCT00031187 Seattle Genetics, Inc. Prostatic Neoplasms October 2000 Phase 2
NCT00665392 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR) Head and Neck Cancer February 2008 Phase 2
NCT00089479 Hoffmann-La Roche Breast Cancer August 2002 Phase 3
NCT01485861 Genentech, Inc. Prostate Cancer January 11, 2012 Phase 1|Phase 2
NCT01876927 Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori Gastric Cancer|Locally Advanced Malignant Neoplasm September 2010 Phase 2
NCT00008125 University of Pittsburgh|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 1998 Phase 1
NCT00872625 Centre Antoine Lacassagne Breast Cancer April 2007 Phase 1
NCT02795572 AHS Cancer Control Alberta Peripheral Neuropathy in Breast Cancer Patient June 2017 Phase 2
NCT01086826 Associazione Volontari Pazienti Oncologici|Mario Negri Institute for Pharmacological Research Head and Neck Squamous Cell Carcinoma March 2008 Phase 3
NCT00256789 Clinical Oncology Research Associates|Aventis Pharmaceuticals Carcinoma, Non-Small-Cell Lung September 2002
NCT00003888 European Organisation for Research and Treatment of Cancer - EORTC Head and Neck Cancer April 1999 Phase 3
NCT02364804 Shiga University Non-small Cell Lung Cancer April 2012